<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1328" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1328/" /><meta name="ncbi_pagename" content="Disorders of Intracellular Cobalamin Metabolism - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Disorders of Intracellular Cobalamin Metabolism - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Disorders of Intracellular Cobalamin Metabolism" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/09/06" /><meta name="citation_author" content="Jennifer L Sloan" /><meta name="citation_author" content="Nuria Carrillo" /><meta name="citation_author" content="David Adams" /><meta name="citation_author" content="Charles P Venditti" /><meta name="citation_pmid" content="20301503" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1328/" /><meta name="citation_keywords" content="cblE" /><meta name="citation_keywords" content="cblC" /><meta name="citation_keywords" content="cblG" /><meta name="citation_keywords" content="cblD-combined" /><meta name="citation_keywords" content="cblD-homocystinuria" /><meta name="citation_keywords" content="cblX" /><meta name="citation_keywords" content="cblF" /><meta name="citation_keywords" content="cbIJ" /><meta name="citation_keywords" content="ATP-binding cassette sub-family D member 4" /><meta name="citation_keywords" content="Host cell factor 1" /><meta name="citation_keywords" content="Methionine synthase" /><meta name="citation_keywords" content="Methionine synthase reductase" /><meta name="citation_keywords" content="Methylmalonic aciduria and homocystinuria type C protein" /><meta name="citation_keywords" content="Methylmalonic aciduria and homocystinuria type D protein, mitochondrial" /><meta name="citation_keywords" content="Probable lysosomal cobalamin transporter" /><meta name="citation_keywords" content="THAP domain-containing protein 11" /><meta name="citation_keywords" content="Zinc finger protein 143" /><meta name="citation_keywords" content="ABCD4" /><meta name="citation_keywords" content="HCFC1" /><meta name="citation_keywords" content="LMBRD1" /><meta name="citation_keywords" content="MMACHC" /><meta name="citation_keywords" content="MMADHC" /><meta name="citation_keywords" content="MTR" /><meta name="citation_keywords" content="MTRR" /><meta name="citation_keywords" content="THAP11" /><meta name="citation_keywords" content="ZNF143" /><meta name="citation_keywords" content="Disorders of Intracellular Cobalamin Metabolism" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Disorders of Intracellular Cobalamin Metabolism" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Jennifer L Sloan" /><meta name="DC.Contributor" content="Nuria Carrillo" /><meta name="DC.Contributor" content="David Adams" /><meta name="DC.Contributor" content="Charles P Venditti" /><meta name="DC.Date" content="2018/09/06" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1328/" /><meta name="description" content="Disorders of intracellular cobalamin metabolism have a variable phenotype and age of onset that are influenced by the severity and location within the pathway of the defect. The prototype and best understood phenotype is cblC; it is also the most common of these disorders. The age of initial presentation of cblC spans a wide range:" /><meta name="og:title" content="Disorders of Intracellular Cobalamin Metabolism" /><meta name="og:type" content="book" /><meta name="og:description" content="Disorders of intracellular cobalamin metabolism have a variable phenotype and age of onset that are influenced by the severity and location within the pathway of the defect. The prototype and best understood phenotype is cblC; it is also the most common of these disorders. The age of initial presentation of cblC spans a wide range:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1328/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cbl/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1328/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CC8CFE0427811000000000166008D.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1328_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1328_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/gnas-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/donnai/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1328_"><span class="title" itemprop="name">Disorders of Intracellular Cobalamin Metabolism</span></h1><p class="contrib-group"><span itemprop="author">Jennifer L Sloan</span>, PhD, MS, <span itemprop="author">Nuria Carrillo</span>, MD, <span itemprop="author">David Adams</span>, MD, PhD, and <span itemprop="author">Charles P Venditti</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1328_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1328_ai__"><div class="contrib half_rhythm"><span itemprop="author">Jennifer L Sloan</span>, PhD, MS<div class="affiliation small">Medical Genomics and Metabolic Genetics Branch<br />National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@naolsj" class="oemail">vog.hin.liam@naolsj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Nuria Carrillo</span>, MD<div class="affiliation small">Medical Genetics Branch<br />National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@nllirrac" class="oemail">vog.hin.liam@nllirrac</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">David Adams</span>, MD, PhD<div class="affiliation small">Medical Genetics Branch<br />National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@1smadad" class="oemail">vog.hin.liam@1smadad</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Charles P Venditti</span>, MD, PhD<div class="affiliation small">Medical Genomics and Metabolic Genetics Branch<br />National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@ittidnev" class="oemail">vog.hin.liam@ittidnev</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 25, 2008</span>; Last Update: <span itemprop="dateModified">September 6, 2018</span>.</p><p><em>Estimated reading time: 49 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cbl.Summary" itemprop="description"><h2 id="_cbl_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Disorders of intracellular cobalamin metabolism have a variable <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and age of onset that are influenced by the severity and location within the pathway of the defect. The prototype and best understood phenotype is <i>cblC</i>; it is also the most common of these disorders. The age of initial presentation of <i>cblC</i> spans a wide range:</p><ul><li class="half_rhythm"><div>In utero with fetal presentation of nonimmune hydrops, cardiomyopathy, and intrauterine growth restriction</div></li><li class="half_rhythm"><div>Newborns, who can have microcephaly, poor feeding, and encephalopathy</div></li><li class="half_rhythm"><div>Infants, who can have poor feeding and slow growth, neurologic abnormality, and, rarely, hemolytic uremic syndrome (HUS)</div></li><li class="half_rhythm"><div>Toddlers, who can have poor growth, progressive microcephaly, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures</div></li><li class="half_rhythm"><div>Adolescents and adults, who can have neuropsychiatric symptoms, progressive cognitive decline, thromboembolic compications, and/or subacute combined degeneration of the spinal cord</div></li></ul></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of a disorder of intracellular cobalamin metabolism in a symptomatic individual is based on clinical, biochemical, and molecular genetic data. Evaluation of the methylmalonic acid (MMA) level in urine and blood and plasma total homocysteine (tHcy) level are the mainstays of biochemical testing. Diagnosis is confirmed by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of the following genes (associated complementation groups indicated in parentheses): <i>MMACHC</i> (<i>cblC</i>), <i>MMADHC</i> (<i>cblD</i>-combined and <i>cblD</i>-homocystinuria), <i>MTRR</i> (<i>cblE</i>), <i>LMBRD1</i> (<i>cblF</i>), <i>MTR</i> (<i>cblG</i>), <i>ABCD4</i> (<i>cblJ</i>), <i>THAP11</i>(<i>cblX</i>-like), <i>ZNF143</i>(<i>cblX</i>-like), or a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> variant in <i>HCFC1</i> (<i>cblX</i>, which can show a <i>cblC</i> complementation class).</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Critically ill individuals must be stabilized, preferably in consultation with a metabolic specialist, by treating acidosis, reversing catabolism, and initiating parenteral hydroxocobalamin. Treatment of thromboembolic complications (e.g., HUS and thrombotic microangiopathy) includes initiation of hydroxocobalamin (OHCbl) and betaine or an increase in their doses. Long-term management focuses on improving the metabolic derangement by lowering plasma tHcy and MMA concentrations and maintaining plasma methionine concentrations within the normal range. Gastrostomy tube placement for feeding may be required; infantile spasms, seizures, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart malformations, and hydrocephalus are treated using standard protocols.</p><p><i>Prevention of primary manifestations:</i> Early institution of injectable hydroxocobalamin improves survival and may reduce but not completely prevent primary manifestations. To prevent metabolic decompensations, patients are advised to avoid situations that result in catabolism, such as prolonged fasting and dehydration, and always remain on a weight-appropriate dose of hydroxocobalamin.</p><p><i>Surveillance:</i> During the first year of life, infants may need to be evaluated once or twice a month by a metabolic specialist to assess growth, nutritional status, feeding ability, and developmental and neurocognitive progress. Toddlers and school-age children should be evaluated at least twice a year to adjust medication dosing (hydroxocobalamin, betaine) during growth and evaluate nutritional status. Teens and adults may be seen on a yearly basis. Routine ophthalmologic, neurologic, and cardiac evaluations may also be appropriate.</p><p><i>Agents/circumstances to avoid:</i> Prolonged fasting (longer than overnight without dextrose-containing intravenous fluids); dietary protein intake below the recommended dietary allowance for age or more than that prescribed by a metabolic specialist; methionine restriction including use of medical foods that do not contain methionine; and the anesthetic nitrous oxide.</p><p><i>Evaluation of relatives at risk:</i> If the pathogenic variants in the family are known, at-risk sibs may be tested prenatally to allow initiation of treatment in utero or as soon as possible after birth.</p><p>If the newborn sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has not undergone prenatal testing, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be performed in the first week of life if the pathogenic variants in the family are known. Otherwise, evaluation of urine organic acids and plasma amino acids, measurement of total plasma homocysteine, serum methylmalonic acid analysis, and acylcarnitine profile analysis can be used for the purpose of early diagnosis and treatment.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>The majority of disorders of intracellular cobalamin metabolism are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. The disorder of intracellular cobalamin metabolism caused by pathogenic variants in <i>HCFC1</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. The risk to sibs depends on the genetic status of the mother. If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has an <i>HCFC1</i>
<a href="https://www.ncbi.nlm.nih.gov/books/n/gene/glossary/def-item/pathogenic-variant/" ref="pagearea=abstract&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be affected. Females who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and will usually not be affected (no affected females have been described to date).</p><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk relatives, molecular genetic prenatal testing for a pregnancy at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="cbl.GeneReview_Scope"><h2 id="_cbl_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="cbl.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1328/table/cbl.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cbl.Td_lrgtbl__"><table><thead><tr><th id="hd_h_cbl.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorders of Intracellular Cobalamin Metabolism: Included Phenotypes</th></tr></thead><tbody><tr><td headers="hd_h_cbl.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div><i>cblC</i></div></li><li class="half_rhythm"><div><i>cblD</i>-combined</div></li><li class="half_rhythm"><div><i>cblD</i>-homocystinuria</div></li><li class="half_rhythm"><div><i>cblE</i></div></li><li class="half_rhythm"><div><i>cblF</i></div></li><li class="half_rhythm"><div><i>cblG</i></div></li><li class="half_rhythm"><div><i>cblJ</i></div></li><li class="half_rhythm"><div><i>cblX</i></div></li></ul>
</td></tr></tbody></table></div></div></div><div id="cbl.Diagnosis"><h2 id="_cbl_Diagnosis_">Diagnosis</h2><p>The disorders of intracellular cobalamin metabolism result from deficient synthesis of the coenzymes derived from vitamin B<sub>12</sub>:</p><ul><li class="half_rhythm"><div>Adenosylcobalamin (AdoCbl) &#x02013; the coenzyme for methylmalonyl-CoA mutase enzyme</div></li><li class="half_rhythm"><div>Methylcobalamin (MeCbl) &#x02013; the coenzyme for the enzyme methionine synthase (MTR) (<a class="figpopup" href="/books/NBK1328/figure/cbl.F1/?report=objectonly" target="object" rid-figpopup="figcblF1" rid-ob="figobcblF1">Figure 1</a>)</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figcblF1" co-legend-rid="figlgndcblF1"><a href="/books/NBK1328/figure/cbl.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figcblF1" rid-ob="figobcblF1"><img class="small-thumb" src="/books/NBK1328/bin/cbl-Image001.gif" src-large="/books/NBK1328/bin/cbl-Image001.jpg" alt="Figure 1. . Intracellular metabolism of cobalamin." /></a><div class="icnblk_cntnt" id="figlgndcblF1"><h4 id="cbl.F1"><a href="/books/NBK1328/figure/cbl.F1/?report=objectonly" target="object" rid-ob="figobcblF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Intracellular metabolism of cobalamin. The intracellular cobalamin metabolism and related pathways &#x02013; including the complementation groups and corresponding genes &#x02013; are shown. Endocytosis of <i>cobalamin</i> bound to its blood carrier transcobalamin <a href="/books/NBK1328/figure/cbl.F1/?report=objectonly" target="object" rid-ob="figobcblF1">(more...)</a></p></div></div><p>This <i>GeneReview</i> describes inborn errors of cobalamin metabolism, including disorders with combined methylmalonic acidemia and homocystinuria caused by AdoCbl and MeCbl deficiency (<a class="figpopup" href="/books/NBK1328/table/cbl.T.disorders_of_intracellular_cobalam/?report=objectonly" target="object" rid-figpopup="figcblTdisordersofintracellularcobalam" rid-ob="figobcblTdisordersofintracellularcobalam">Table 1</a> &#x02013; B) as well as disorders associated with homocystinuria (MeCbl deficiency) (<a class="figpopup" href="/books/NBK1328/table/cbl.T.disorders_of_intracellular_cobalam/?report=objectonly" target="object" rid-figpopup="figcblTdisordersofintracellularcobalam" rid-ob="figobcblTdisordersofintracellularcobalam">Table 1</a> - C). For disorders associated with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia (AdoCbl deficiency) (<a class="figpopup" href="/books/NBK1328/table/cbl.T.disorders_of_intracellular_cobalam/?report=objectonly" target="object" rid-figpopup="figcblTdisordersofintracellularcobalam" rid-ob="figobcblTdisordersofintracellularcobalam">Table 1</a> &#x02013; A) see <a href="/books/n/gene/mma/">Isolated Methylmalonic Acidemia</a>).</p><p>Note: All the disorders of intracellular cobalamin metabolism are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner except for <i>cblX</i> (associated with pathogenic variants in <i>HCFC1</i>), which is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p><div id="cbl.T.disorders_of_intracellular_cobalam" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Disorders of Intracellular Cobalamin Metabolism by Biochemical Phenotype</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1328/table/cbl.T.disorders_of_intracellular_cobalam/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cbl.T.disorders_of_intracellular_cobalam_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Biochemical Phenotype</th><th id="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complementation Group&#x000a0;<sup>1</sup></th><th id="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th></tr></thead><tbody><tr><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">A. <a href="/books/n/gene/mma/">Methylmalonic acidemia</a> (AdoCbl deficiency)&#x000a0;<sup>2</sup></td><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblA</i></td><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MMAA</i></td></tr><tr><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>cblB</i></td><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MMAB</i></td></tr><tr><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>cblD</i>-methylmalonic aciduria</td><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MMADHC</i>&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">B. Combined methylmalonic acidemia and homocystinuria&#x000a0;<sup>4</sup> (AdoCbl and MeCbl deficiency)</td><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblC</i>&#x000a0;<sup>5</sup></td><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MMACHC</i>&#x000a0;<sup>6</sup><br /><i>PRDX1</i>&#x000a0;<sup>7</sup><br /><i>HCFC1</i>&#x000a0;<sup>8</sup> (<i>cblX</i>)<br /><i>THAP11</i>&#x000a0;<sup>7</sup><br /><i>ZNF143</i>&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>cblD</i>-combined</td><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MMADHC</i>&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>cblF</i></td><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LMBRD1</i></td></tr><tr><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>cblJ</i></td><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ABCD4</i>&#x000a0;<sup>10</sup></td></tr><tr><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">C. Homocystinuria&#x000a0;<sup>4</sup> (MeCbl deficiency)</td><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblD</i>-homocystinuria</td><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MMADHC</i>&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>cblE</i></td><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MTRR</i></td></tr><tr><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>cblG</i></td><td headers="hd_h_cbl.T.disorders_of_intracellular_cobalam_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MTR</i></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note: The terms methylmalonic acidemia and methylmalonic aciduria are synonymous, as are the terms hyperhomocysteinemia and homocystinuria.</p></div></dd><dt>1. </dt><dd><div id="cbl.TF.1.1"><p class="no_margin">The nomenclature for inherited disorders of intracellular cobalamin metabolism is based on cellular complementation analysis that defines cobalamin groups A-J (<i>cblA</i> - <i>cblJ</i>). The name of each disorder is prefixed with "cbl" (for cobalamin) followed by a unique capital letter for its complementation group determined by somatic cell analysis (e.g., <i>cblC</i> represents complementation group C).</p></div></dd><dt>2. </dt><dd><div id="cbl.TF.1.2"><p class="no_margin"><i>cblA</i>, <i>cblB</i>, and <i>cblD</i>-methylmalonic aciduria are discussed in detail in <a href="/books/n/gene/mma/">Isolated Methylmalonic Acidemia</a> and briefly under <a href="#cbl.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd><dt>3. </dt><dd><div id="cbl.TF.1.3"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.coelho.2008.1454">Coelho et al [2008]</a></p></div></dd><dt>4. </dt><dd><div id="cbl.TF.1.4"><p class="no_margin">The homocystinuria seen in disorders of intracellular cobalamin metabolism is associated with low/normal methionine in contrast to the <a href="/books/n/gene/homocystinuria/">homocystinuria</a> seen in cystathionine beta-synthase deficiency, which is associated with high methionine (see <a class="figpopup" href="/books/NBK1328/figure/cbl.F1/?report=objectonly" target="object" rid-figpopup="figcblF1" rid-ob="figobcblF1">Figure 1</a>).</p></div></dd><dt>5. </dt><dd><div id="cbl.TF.1.5"><p class="no_margin">Individuals with <i>cblX</i> can show a <i>cblC</i> complementation class.</p></div></dd><dt>6. </dt><dd><div id="cbl.TF.1.6"><p class="no_margin">A rare complex variant of <i>MMACHC</i> and adjacent <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>PRDX1</i> has been described [<a class="bk_pop" href="#cbl.REF.gu_ant.2018.554">Gu&#x000e9;ant et al 2018</a>]; see <a href="#cbl.Molecular_Genetics">Molecular Genetics</a>.</p></div></dd><dt>7. </dt><dd><div id="cbl.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.quintana.2017.2838">Quintana et al [2017]</a></p></div></dd><dt>8. </dt><dd><div id="cbl.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.yu.2013.506">Yu et al [2013]</a></p></div></dd><dt>9. </dt><dd><div id="cbl.TF.1.9"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.pupavac.2016.976">Pupavac et al [2016]</a></p></div></dd><dt>10. </dt><dd><div id="cbl.TF.1.10"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.coelho.2012.1152">Coelho et al [2012]</a></p></div></dd></dl></div></div></div><p>The diagnosis of a disorder of intracellular cobalamin metabolism in a symptomatic individual is based on clinical, biochemical, and molecular genetic data. With the availability of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, <a href="#cbl.Complementation_Group_Analysis">complementation group analysis</a> is no longer frequently used.</p><div id="cbl.Suggestive_Findings"><h3>Suggestive Findings</h3><p>A disorder of intracellular cobalamin metabolism <b>should be suspected</b> in individuals with the following physical and laboratory findings.</p><p><b>Physical findings</b></p><ul><li class="half_rhythm"><div><b>In utero.</b> Nonimmune hydrops, cardiomyopathy, intrauterine growth restriction</div></li><li class="half_rhythm"><div><b>Newborns.</b> Microcephaly, poor feeding, encephalopathy</div></li><li class="half_rhythm"><div><b>Infants.</b> Poor feeding and slow growth, hypotonia, developmental delay, seizures including infantile spasms, infantile maculopathy. Rarely, hemolytic uremic syndrome and obtundation.</div></li><li class="half_rhythm"><div><b>Toddlers.</b> Poor growth, progressive microcephaly, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, hypotonia, seizures</div></li><li class="half_rhythm"><div><b>Adolescents and adults.</b> Neuropsychiatric symptoms, progressive cognitive decline, thromboembolic complications, subacute combined degeneration of the spinal cord</div></li></ul><p><b>Laboratory findings</b></p><ul><li class="half_rhythm"><div>Macrocytic anemia with normal B<sub>12</sub> levels, thrombocytopenia, and/or neutropenia</div></li><li class="half_rhythm"><div>Hyperammonemia and/or metabolic acidosis in infancy (rare)</div></li></ul><p><b>Newborn with abnormal <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a></b> based on elevated C3 propionylcarnitine or decreased methionine (see ACMG ACT Sheetsfor <a href="http://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">C3</a> and <a href="http://www.acmg.net/PDFLibrary/Methionine-Algorithm.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">methionine</a>)</p><ul><li class="half_rhythm"><div>Detection by <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> (NBS) depends on the C3 and C3/C2 ratio cutoff values used by reference laboratories and the availability of detection of low methionine [<a class="bk_pop" href="#cbl.REF.chace.2001.2040">Chace et al 2001</a>, <a class="bk_pop" href="#cbl.REF.weisfeldadams.2010.116">Weisfeld-Adams et al 2010</a>, <a class="bk_pop" href="#cbl.REF.huemer.2015b.1007">Huemer et al 2015b</a>]. <i>cblD</i>-homocystinuria, <i>cblE</i>, and <i>cblG</i> do not have elevated C3 and are often not identified on newborn screening. In some US states, detection of low methionine and the use of an NBS tool (<a href="https://clir.mayo.edu/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">clir.mayo.edu</a>; registration required) in combination with measurement of homocysteine has sucessfully identified individuals with <i>cblE</i> and <i>cblG</i> [<a class="bk_pop" href="#cbl.REF.wong.2016.162">Wong et al 2016</a>].</div></li><li class="half_rhythm"><div>Since NBS potentially allows early detection of certain disorders of intracellular cobalamin metabolism, some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may be diagnosed before the onset of symptoms.</div></li></ul></div><div id="cbl.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of a disorder of intracellular cobalamin metabolism <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with specific biochemical testing results (see <a href="#cbl.Biochemical_Testing">Biochemical Testing</a> and <a class="figpopup" href="/books/NBK1328/table/cbl.T.metabolite_concentrations_in_disor/?report=objectonly" target="object" rid-figpopup="figcblTmetaboliteconcentrationsindisor" rid-ob="figobcblTmetaboliteconcentrationsindisor">Table 2</a>) and confirmed by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of the genes listed in <a class="figpopup" href="/books/NBK1328/table/cbl.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figcblTmoleculargenetictestingusedin" rid-ob="figobcblTmoleculargenetictestingusedin">Table 3</a> &#x02013; with the exception of <i>HCFC1</i>, in which a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is confirmatory. For equivocal <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> results, enzymatic testing on skin fibroblasts can be used.</p><div id="cbl.Biochemical_Testing"><h4>Biochemical Testing</h4><p>The identification of disorders of intracellular cobalamin metabolism relies on the following testing (<a class="figpopup" href="/books/NBK1328/table/cbl.T.metabolite_concentrations_in_disor/?report=objectonly" target="object" rid-figpopup="figcblTmetaboliteconcentrationsindisor" rid-ob="figobcblTmetaboliteconcentrationsindisor">Table 2</a>):</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Urine organic acid (UOA) analysis</b> to screen for elevation of methylmalonic acid (MMA). Other secondary metabolites such as 3-hydroxypropionate, methylcitrate, and tiglylglycine may be seen transiently in symptomatic <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Serum methylmalonic acid analysis</b> is more quantitative than urine organic acid analysis.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Total plasma homocysteine (tHcy) analysis</b> is the preferred method of detecting plasma homocysteine.</div><div class="half_rhythm">Note: Delays in separating serum from plasma after obtaining a blood sample can artificially increase total homocysteine by as much as 10% an hour [<a class="bk_pop" href="#cbl.REF.ubbink.2000.233">Ubbink 2000</a>, <a class="bk_pop" href="#cbl.REF.refsum.2004.3">Refsum et al 2004</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Plasma amino acid (PAA) analysis.</b> Hypomethioninemia, seen in disorders with defective MeCbl synthesis, helps differentiate disorders of intracellular cobalamin metabolism from other causes of homocystinuria, such as cystathionine beta-synthase deficiency, in which methionine level is elevated (see <a href="#cbl.Differential_Diagnosis">Differential Diagnosis</a>, <b>Cystathionine beta-synthase deficiency</b>).</div><div class="half_rhythm">Other findings that can be seen on PAA analysis:</div><ul><li class="half_rhythm"><div>Hyperhomocysteinemia and mixed disulfides (which are also excreted in the urine)</div></li><li class="half_rhythm"><div>Cystathionine (which is also excreted in the urine) in individuals with <i>cblC</i></div></li></ul></li><li class="half_rhythm"><div class="half_rhythm"><b>Serum vitamin B<sub>12</sub> levels</b> to exclude vitamin B<sub>12</sub> deficiency</div><div class="half_rhythm">Note: <i>cblF</i> and <i>cblJ</i> disorders are the exceptions and have been reported to have low B<sub>12</sub> levels at diagnosis.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Plasma acylcarnitine analysis</b> to detect elevation of propionylcarnitine (C3) or confirm the elevated propionylcarnitine following <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a></div></li></ul><div id="cbl.T.metabolite_concentrations_in_disor" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Metabolite Concentrations in Disorders of Intracellular Cobalamin Metabolism</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1328/table/cbl.T.metabolite_concentrations_in_disor/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cbl.T.metabolite_concentrations_in_disor_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" rowspan="2" colspan="2" scope="colgroup" headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" style="text-align:left;vertical-align:middle;"></th><th id="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Methylmalonic Acid</th><th id="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" style="text-align:left;vertical-align:middle;">Plasma Total Homocysteine (tHcy)</th><th id="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" rowspan="2" scope="col" colspan="1" headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" style="text-align:left;vertical-align:middle;">Plasma Methionine</th></tr><tr><th headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2" id="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Urine</th><th headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2" id="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Blood</th></tr></thead><tbody><tr><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Biochemical Phenotype</b></td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><b>Complementation Group</b></td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" colspan="4" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Normal Values</b></td></tr><tr><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;4 mmol/mol/Cr&#x000a0;<sup>1</sup></td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;0.27 &#x000b5;mol/L&#x000a0;<sup>1</sup></td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3-13 &#x000b5;mol/L</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11-37 &#x000b5;mol/L</td></tr><tr><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Values by Biochemical Phenotype</b></td></tr><tr><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Combined AdoCbl &#x00026; MeCbl deficiency</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblC</i>&#x000a0;<sup>1</sup></td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100s to low 1,000s of mmol/mol Cr when ill or at presentation; generally ranging from 10s to 100s mmol/mol Cr during treatment</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100s of &#x000b5;mol/L at presentation and when ill; 1-10 &#x000b5;mol/L when well &#x00026; treated&#x000a0;<sup>2</sup></td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;100 when ill; 20-80 &#x000b5;mol/L when well &#x00026; treated&#x000a0;<sup>2</sup></td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low to normal</td></tr><tr><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>cblD</i>-combined&#x000a0;<sup>3</sup></td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Can be &#x0003e;1,000 mmol/mol Cr</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NR</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;100 &#x000b5;mol/L in some cases</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low to normal</td></tr><tr><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>cblF</i>&#x000a0;<sup>4</sup></td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">200 mmol/mol/Cr when untreated; normal during treatment</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal when treated</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Increased when untreated; normal when treated</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td></tr><tr><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>cblJ</i>&#x000a0;<sup>5</sup></td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Increased</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Increased</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Increased</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low to normal</td></tr><tr><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>cblX</i>&#x000a0;<sup>6,&#x000a0;7,&#x000a0;8</sup></td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Increased</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Increased</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal to increased</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low to normal</td></tr><tr><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">MeCbl deficiency</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblD</i>-homocystinuria&#x000a0;<sup>3</sup></td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;100 &#x000b5;mol/L in some cases</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low to normal</td></tr><tr><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>cblE</i></td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal&#x000a0;<sup>9</sup></td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;100 &#x000b5;mol/L when ill</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low&#x000a0;<sup>10</sup></td></tr><tr><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>cblG</i></td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_2 hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Increased</td><td headers="hd_h_cbl.T.metabolite_concentrations_in_disor_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low&#x000a0;<sup>10</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">NR = not reported</p></div></dd><dt>1. </dt><dd><div id="cbl.TF.2.1"><p class="no_margin">Standard values have not been exclusively derived from children or neonates. Some laboratories report urine methylmalonic acid (MMA) concentrations in mg/g/Cr (normal: &#x0003c;3 mg/g/Cr) and serum concentrations in nmol/L (normal: &#x0003c;271 nmol/L). The molecular weight of MMA is 118 g/mol.</p></div></dd><dt>2. </dt><dd><div id="cbl.TF.2.2"><p class="no_margin">Authors' experience with &#x0003e;50 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</p></div></dd><dt>3. </dt><dd><div id="cbl.TF.2.3"><p class="no_margin">Values refer to <i>cblD</i>-combined and <i>cblD</i>-homocystinuria.</p></div></dd><dt>4. </dt><dd><div id="cbl.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.alfadhel.2011.2571">Alfadhel et al [2011]</a></p></div></dd><dt>5. </dt><dd><div id="cbl.TF.2.5"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.kim.2012.664">Kim et al [2012]</a></p></div></dd><dt>6. </dt><dd><div id="cbl.TF.2.6"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.yu.2013.506">Yu et al [2013]</a></p></div></dd><dt>7. </dt><dd><div id="cbl.TF.2.7"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.pupavac.2016.976">Pupavac et al [2016]</a></p></div></dd><dt>8. </dt><dd><div id="cbl.TF.2.8"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.quintana.2017.2838">Quintana et al [2017]</a></p></div></dd><dt>9. </dt><dd><div id="cbl.TF.2.9"><p class="no_margin">Mild elevation uncommon [<a class="bk_pop" href="#cbl.REF.tuchman.1988.1052">Tuchman et al 1988</a>]</p></div></dd><dt>10. </dt><dd><div id="cbl.TF.2.10"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.watkins.2014">Watkins &#x00026; Rosenblatt [2014]</a></p></div></dd></dl></div></div></div></div><div id="cbl.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (concurrent or serial single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Individuals with the distinctive laboratory findings of a specific disorder of intracellular cobalamin metabolism described in <a href="#cbl.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing (see <a href="#cbl.Option_1">Option 1</a>), whereas symptomatic individuals with nonspecific supportive clinical and laboratory findings in whom the diagnosis of a disorder of intracellular cobalamin metabolism has not been considered are more likely to be diagnosed using comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (see <a href="#cbl.Option_2">Option 2</a>).</p></div><div id="cbl.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of a disorder of intracellular cobalamin metabolism, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>MMACHC</i> first in individuals with biochemical findings of combined AdoCbl and MeCbl deficiency as it is by far the most commonly associated gene (<a class="figpopup" href="/books/NBK1328/figure/cbl.F2/?report=objectonly" target="object" rid-figpopup="figcblF2" rid-ob="figobcblF2">Figure 2</a>). If only one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications. If single-gene testing is nondiagnostic, a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> is the next step.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> for inherited disorders of intracellular cobalamin metabolism that includes the genes listed in <a class="figpopup" href="/books/NBK1328/table/cbl.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figcblTmoleculargenetictestingusedin" rid-ob="figobcblTmoleculargenetictestingusedin">Table 3</a> and other genes of interest (see <a href="#cbl.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For this disorder a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that also includes <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> can be considered if <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> has not identified two pathogenic variants in an individual with strong biochemical evidence for a disorder of intracellular cobalamin metabolism.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figcblF2" co-legend-rid="figlgndcblF2"><a href="/books/NBK1328/figure/cbl.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figcblF2" rid-ob="figobcblF2"><img class="small-thumb" src="/books/NBK1328/bin/cbl-Image002.gif" src-large="/books/NBK1328/bin/cbl-Image002.jpg" alt="Figure 2. " /></a><div class="icnblk_cntnt" id="figlgndcblF2"><h4 id="cbl.F2"><a href="/books/NBK1328/figure/cbl.F2/?report=objectonly" target="object" rid-ob="figobcblF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Testing algorithm to confirm the diagnosis of a disorder of intracellular cobalamin metabolism in a proband 1. While diagnostic testing is being performed, contact genetics/metabolic team and initiate treatment <i>immediately</i>.</p></div></div></div><div id="cbl.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders characterized by the wide of array of possible nonspecific clinical findings or an individual has atypical phenotypic features of a disorder of intracellular cobalamin metabolism, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="cbl.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Disorders of Intracellular Cobalamin Metabolism</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1328/table/cbl.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cbl.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Complementation Group / Disorder</th><th id="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_3" style="text-align:left;vertical-align:middle;">Proportion of Disorders of Intracellular Cobalamin Metabolism Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detected by Test Method</th></tr><tr><th headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4" id="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></th><th headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4" id="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4</sup></th></tr></thead><tbody><tr><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MMACHC</i></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblC</i></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">80%</td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">96%-98%&#x000a0;<sup>5,&#x000a0;6,&#x000a0;7</sup></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8,&#x000a0;9</sup></td></tr><tr><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MMADHC</i></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblD</i>-combined; <i>cblD</i>-homocystinuria</td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22/22&#x000a0;<sup>10</sup></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MTRR</i></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblE</i></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">21/22&#x000a0;<sup>11</sup></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LMBRD1</i></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblF</i></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23/24&#x000a0;<sup>12</sup></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">One reported&#x000a0;<sup>13</sup></td></tr><tr><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MTR</i></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblG</i></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%</td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">64/74&#x000a0;<sup>11</sup></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ABCD4</i></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblJ</i></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;&#x0003c;1%</td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12/12&#x000a0;<sup>14</sup></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HCFC1</i></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblX</i></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14/17&#x000a0;<sup>15,&#x000a0;16</sup></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>THAP11</i></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not yet defined-<i>cblX</i>-like</td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Single case report&#x000a0;<sup>17</sup></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ZNF143</i></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not yet defined-<i>cblX</i>-like</td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Single case report&#x000a0;<sup>18</sup></td><td headers="hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_cbl.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Genes are listed in order of complementation group number.</p></div></dd><dt>1. </dt><dd><div id="cbl.TF.3.1"><p class="no_margin">See <a href="/books/NBK1328/#cbl.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="cbl.TF.3.2"><p class="no_margin">See <a href="#cbl.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="cbl.TF.3.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="cbl.TF.3.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>5. </dt><dd><div id="cbl.TF.3.5"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.liu.2010.621">Liu et al [2010]</a></p></div></dd><dt>6. </dt><dd><div id="cbl.TF.3.6"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.lernerellis.2009.1072">Lerner-Ellis et al [2009]</a></p></div></dd><dt>7. </dt><dd><div id="cbl.TF.3.7"><p class="no_margin">A rare complex variant of <i>MMACHC</i> and adjacent genes has been described [<a class="bk_pop" href="#cbl.REF.gu_ant.2018.554">Gu&#x000e9;ant et al 2018</a>].</p></div></dd><dt>8. </dt><dd><div id="cbl.TF.3.8"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd><dt>9. </dt><dd><div id="cbl.TF.3.9"><p class="no_margin">One <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> individual has been found to have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>MMACHC</i> whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions [Author, unpublished observation].</p></div></dd><dt>10. </dt><dd><div id="cbl.TF.3.10"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.stucki.2012.1410">Stucki et al [2012]</a></p></div></dd><dt>11. </dt><dd><div id="cbl.TF.3.11"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.watkins.2002.143">Watkins et al [2002]</a>, <a class="bk_pop" href="#cbl.REF.huemer.2015b.1007">Huemer et al [2015b]</a>. One deep <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been reported [<a class="bk_pop" href="#cbl.REF.zavad_kov_.2005.239">Zavad&#x000e1;kov&#x000e1; et al 2005</a>, <a class="bk_pop" href="#cbl.REF.homolova.2010.437">Homolova et al 2010</a>] (detailed in <a href="#cbl.Molecular_Genetics">Molecular Genetics</a>).</p></div></dd><dt>12. </dt><dd><div id="cbl.TF.3.12"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.rutsch.2009.234">Rutsch et al [2009]</a></p></div></dd><dt>13. </dt><dd><div id="cbl.TF.3.13"><p class="no_margin">A <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> spanning <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 was reported by <a class="bk_pop" href="#cbl.REF.miousse.2011.505">Miousse et al [2011]</a>.</p></div></dd><dt>14. </dt><dd><div id="cbl.TF.3.14"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.coelho.2012.1152">Coelho et al [2012]</a></p></div></dd><dt>15. </dt><dd><div id="cbl.TF.3.15"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.yu.2013.506">Yu et al [2013]</a></p></div></dd><dt>16. </dt><dd><div id="cbl.TF.3.16"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>17. </dt><dd><div id="cbl.TF.3.17"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.quintana.2017.2838">Quintana et al [2017]</a></p></div></dd><dt>18. </dt><dd><div id="cbl.TF.3.18"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.pupavac.2016.976">Pupavac et al [2016]</a></p></div></dd></dl></div></div></div></div></div><div id="cbl.Complementation_Group_Analysis"><h3>Complementation Group Analysis</h3><p>Complementation analysis is a method used historically to diagnose the specific defects of intracellular cobalamin metabolism using cultured skin fibroblasts [<a class="bk_pop" href="#cbl.REF.watkins.1986.404">Watkins &#x00026; Rosenblatt 1986</a>]. Because of the availability of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> this method is now performed infrequently, but it may still be useful for individuals with equivocal molecular results.</p></div></div><div id="cbl.Clinical_Characteristics"><h2 id="_cbl_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cbl.Clinical_Description"><h3>Clinical Description</h3><p>Disorders of intracellular cobalamin metabolism have a variable <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (<a class="figpopup" href="/books/NBK1328/table/cbl.T.clinical_manifestations_of_disorde/?report=objectonly" target="object" rid-figpopup="figcblTclinicalmanifestationsofdisorde" rid-ob="figobcblTclinicalmanifestationsofdisorde">Table 4</a>) and age of onset that are influenced by the severity and location within the pathway of the defect.</p><div id="cbl.T.clinical_manifestations_of_disorde" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Clinical Manifestations of Disorders of Intracellular Cobalamin Metabolism</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1328/table/cbl.T.clinical_manifestations_of_disorde/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cbl.T.clinical_manifestations_of_disorde_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_1" style="text-align:left;vertical-align:middle;"></th><th id="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" style="text-align:left;vertical-align:middle;">Manifestations</th><th id="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3" colspan="5" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Combined AdoCbl and MeCbl Deficiency</th><th id="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4" colspan="3" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:top;">MeCbl Deficiency</th></tr><tr><th headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3" id="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"><i>cblC</i>&#x000a0;<sup>1</sup></th><th headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3" id="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblD</i>&#x000a0;<sup>2</sup></th><th headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3" id="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblF</i>&#x000a0;<sup>3</sup></th><th headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3" id="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblJ</i>&#x000a0;<sup>4</sup></th><th headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3" id="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>cblX</i>&#x000a0;<sup>5</sup></th><th headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4" id="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><i>cblD</i>&#x000a0;<sup>2</sup></th><th headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4" id="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblE</i>&#x000a0;<sup>6</sup></th><th headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4" id="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>cblG</i>&#x000a0;<sup>6</sup></th></tr></thead><tbody><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_1" rowspan="11" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Perinatal</b></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Intrauterine growth retardation</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>7</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Microcephaly</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Hydrops fetalis</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Dysmorphic features</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+/-&#x000a0;<sup>8</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+/-</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Congenital heart disease</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>9</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Fetal dilated cardiomyopathy</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Hydrocephalus</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Brain malformations</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+/-</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Cardiomyopathy w/left ventricular noncompaction</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_1" rowspan="27" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Infantile &#x00026; childhood</b></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Acute metabolic decompensation</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Lethargy</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Progressive encephalopathy</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Seizures</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Ataxia</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Hypotonia</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Developmental delay / intellectual disability</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Demyelinating neuropathy</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Dystonia</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Microcephaly</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Subdural hematoma</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>10</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Feeding difficulties</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Failure to thrive</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Nystagmus</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>11</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Retinal degeneration</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>11</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Maculopathy</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Optic atrophy</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>11</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Megaloblastic anemia, cytopenias</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Recurrent infections</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Stomatitis, glossitis</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Hemolytic uremic syndrome</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>12</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>13</sup></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Cerebral atrophy</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Transient ischemic attack</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Dysmorphic features</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Self-injurious behaviors</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Infantile spasms</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Hyperammonemia</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Skin pigmentation abnormalities</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_1" rowspan="13" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Adolescent &#x00026; adulthood</b></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive encephalopathy</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Leukoencephalopathy</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>14</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Psychosis</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>15</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Dementia</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>15</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Neuropsychiatric symptoms</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>15</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Executive dysfunction</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>14</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Subacute combined degeneration of the spinal cord</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>15</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>16</sup></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Glomerulopathy</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>17</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Thromboembolic microangiopathy</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>18</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deep venous thrombosis</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>15</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Pulmonary thromboembolism</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>19</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Stroke</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>20</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Marfanoid features</td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>21</sup></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_3 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_1_4 hd_h_cbl.T.clinical_manifestations_of_disorde_1_1_2_8" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cbl.TF.4.1"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.nogueira.2008.475">Nogueira et al [2008]</a></p></div></dd><dt>2. </dt><dd><div id="cbl.TF.4.2"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.suormala.2004.42742">Suormala et al [2004]</a>, <a class="bk_pop" href="#cbl.REF.coelho.2008.1454">Coelho et al [2008]</a>, <a class="bk_pop" href="#cbl.REF.miousse.2009.551">Miousse et al [2009]</a></p></div></dd><dt>3. </dt><dd><div id="cbl.TF.4.3"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.gailus.2010.17">Gailus et al [2010]</a>, <a class="bk_pop" href="#cbl.REF.alfadhel.2011.2571">Alfadhel et al [2011]</a></p></div></dd><dt>4. </dt><dd><div id="cbl.TF.4.4"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.coelho.2012.1152">Coelho et al [2012]</a>, <a class="bk_pop" href="#cbl.REF.kim.2012.664">Kim et al [2012]</a></p></div></dd><dt>5. </dt><dd><div id="cbl.TF.4.5"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.yu.2013.506">Yu et al [2013]</a></p></div></dd><dt>6. </dt><dd><div id="cbl.TF.4.6"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.watkins.2014">Watkins &#x00026; Rosenblatt [2014]</a></p></div></dd><dt>7. </dt><dd><div id="cbl.TF.4.7"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.frattini.2010.135">Frattini et al [2010]</a></p></div></dd><dt>8. </dt><dd><div id="cbl.TF.4.8"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.cerone.1999.247">Cerone et al [1999]</a></p></div></dd><dt>9. </dt><dd><div id="cbl.TF.4.9"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.profitlich.2009.344">Profitlich et al [2009]</a></p></div></dd><dt>10. </dt><dd><div id="cbl.TF.4.10"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.francis.2004.420">Francis et al [2004]</a></p></div></dd><dt>11. </dt><dd><div id="cbl.TF.4.11"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.gaillard.2008.491">Gaillard et al [2008]</a></p></div></dd><dt>12. </dt><dd><div id="cbl.TF.4.12"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.kind.2002.327">Kind et al [2002]</a>, <a class="bk_pop" href="#cbl.REF.sharma.2007.2097">Sharma et al [2007]</a></p></div></dd><dt>13. </dt><dd><div id="cbl.TF.4.13"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.labrune.1999.734">Labrune et al [1999]</a></p></div></dd><dt>14. </dt><dd><div id="cbl.TF.4.14"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.boxer.2005.1431">Boxer et al [2005]</a></p></div></dd><dt>15. </dt><dd><div id="cbl.TF.4.15"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.powers.2001.396">Powers et al [2001]</a>, <a class="bk_pop" href="#cbl.REF.roze.2003.1457">Roze et al [2003]</a></p></div></dd><dt>16. </dt><dd><div id="cbl.TF.4.16"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.carmel.1988.1738">Carmel et al [1988]</a></p></div></dd><dt>17. </dt><dd><div id="cbl.TF.4.17"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.brunelli.2002.800">Brunelli et al [2002]</a></p></div></dd><dt>18. </dt><dd><div id="cbl.TF.4.18"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.van_hove.2002.195">Van Hove et al [2002]</a>, <a class="bk_pop" href="#cbl.REF.guigonis.2005.588">Guigonis et al [2005]</a></p></div></dd><dt>19. </dt><dd><div id="cbl.TF.4.19"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.brandstetter.1990.167">Brandstetter et al [1990]</a></p></div></dd><dt>20. </dt><dd><div id="cbl.TF.4.20"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.geraghty.1992.934">Geraghty et al [1992]</a></p></div></dd><dt>21. </dt><dd><div id="cbl.TF.4.21"><p class="no_margin"><a class="bk_pop" href="#cbl.REF.heil.2007.811">Heil et al [2007]</a></p></div></dd></dl></div></div></div><div id="cbl.Combined_Methylmalonic_Acidemia_and"><h4>Combined Methylmalonic Acidemia and Homocystinuria</h4></div><div id="cbl.cblC_and_cblDCombined_Types"><h4><i>cblC</i> and <i>cblD</i>-Combined Types</h4><p><i>cblC</i>, the most common of the disorders of intracellular cobalamin metabolism, is the best understood clinically and is described here as a prototype for combined methylmalonic acidemia and homocystinuria. In <i>cblC</i>, age of onset ranges from prenatal to adult. The infantile presentation is the most frequently recognized.</p><p><b>Perinatal manifestations.</b> Intrauterine growth restriction (IUGR) has been seen in infants with <i>cblC</i> [<a class="bk_pop" href="#cbl.REF.nogueira.2008.475">Nogueira et al 2008</a>, <a class="bk_pop" href="#cbl.REF.frattini.2010.135">Frattini et al 2010</a>] and <i>cblF</i> [<a class="bk_pop" href="#cbl.REF.alfadhel.2011.2571">Alfadhel et al 2011</a>].</p><p>Other manifestations can include the following [<a class="bk_pop" href="#cbl.REF.francis.2004.420">Francis et al 2004</a>, <a class="bk_pop" href="#cbl.REF.smith.2006.138">Smith et al 2006</a>, <a class="bk_pop" href="#cbl.REF.profitlich.2009.344">Profitlich et al 2009</a>]:</p><ul><li class="half_rhythm"><div>Microcephaly</div></li><li class="half_rhythm"><div>Congenital heart malformation</div></li><li class="half_rhythm"><div>Dilated cardiomyopathy</div></li><li class="half_rhythm"><div>Hydrocephalus</div></li><li class="half_rhythm"><div>Mild <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features (long face, high forehead, smooth philtrum, and low-set ears) [<a class="bk_pop" href="#cbl.REF.cerone.1999.247">Cerone et al 1999</a>]</div></li></ul><p><b>Infantile presentation.</b> This severe presentation is progressive and may be lethal unless treated. The absence of an acute metabolic presentation or the presence of a normal newborn screen result does not rule out the diagnosis of a disorder of intracellular cobalamin metabolism [<a class="bk_pop" href="#cbl.REF.harding.2003.384">Harding et al 2003</a>, <a class="bk_pop" href="#cbl.REF.ahrensnicklas.2015.71">Ahrens-Nicklas et al 2015</a>].</p><ul><li class="half_rhythm"><div>Infants may present with the following:</div><ul><li class="half_rhythm"><div>Failure to thrive, poor feeding, and hypotonia in the first weeks of life</div></li><li class="half_rhythm"><div>An acute metabolic derangement (high anion gap metabolic acidosis, ketonuria, and hyperammonemia)</div></li><li class="half_rhythm"><div>Hemolytic uremic syndrome (HUS) that may be fatal if treatment with daily hydroxocobalamin (OHCbl) is not initiated promptly [<a class="bk_pop" href="#cbl.REF.kind.2002.327">Kind et al 2002</a>, <a class="bk_pop" href="#cbl.REF.sharma.2007.2097">Sharma et al 2007</a>, <a class="bk_pop" href="#cbl.REF.carrillocarrasco.2012.103">Carrillo-Carrasco &#x00026; Venditti 2012</a>]</div></li></ul></li><li class="half_rhythm"><div>Untreated infants may have multiorgan involvement, neurologic deterioration, seizures (i.e., infantile spasms), and encephalopathy.</div></li><li class="half_rhythm"><div>Maculopathy and progressive retinopathy develop in most individuals with infantile <i>cblC</i>.</div><ul><li class="half_rhythm"><div>The initial manifestations are "wandering eye movements," ocular fixation difficulties, and nystagmus.</div></li><li class="half_rhythm"><div>Fundoscopic changes (which can be detected by careful examination as early as the first month of life) are characterized by abnormal macular pigmentation, "bull's-eye" macula, or macular coloboma; the retinal disease evolves over time into pigmentary retinopathy and optic nerve atrophy [<a class="bk_pop" href="#cbl.REF.brooks.2016.571">Brooks et al 2016</a>].</div></li><li class="half_rhythm"><div>Note: Adolescent and adult (late-onset) presentations of <i>cblC</i> and other inborn errors of cobalamin metabolism do not typically have the ophthalmologic complications. Optic atrophy and other eye findings such as nystagmus and strabismus have been described in <i>cblG</i> [<a class="bk_pop" href="#cbl.REF.poloschek.2005.497">Poloschek et al 2005</a>, <a class="bk_pop" href="#cbl.REF.huemer.2015a.957">Huemer et al 2015a</a>].</div></li></ul></li></ul><p><b>Childhood presentation (first years of life).</b> Failure to thrive, poor head growth, cytopenias (including megaloblastic anemia), global developmental delay, encephalopathy, and neurologic signs such as hypotonia and seizures are typical. Renal thrombotic microangiopathy, HUS, pulmonary hypertension, and diffuse lung disease can also be seen [<a class="bk_pop" href="#cbl.REF.k_mhoff.2013.e540">K&#x000f6;mhoff et al 2013</a>, <a class="bk_pop" href="#cbl.REF.beck.2017.733">Beck et al 2017</a>, <a class="bk_pop" href="#cbl.REF.liu.2017.58">Liu et al 2017</a>].</p><p><b>Adolescent and adult presentation.</b> Individuals with this presentation usually have predominant <b>neurologic and neuropsychiatric</b> manifestations including the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">Neuropsychiatric symptoms (behavioral and personality changes, social withdrawal, visual and auditory hallucinations, delirium, psychosis) [<a class="bk_pop" href="#cbl.REF.huemer.2014.161">Huemer et al 2014</a>]</div></li><li class="half_rhythm"><div class="half_rhythm">Progressive cognitive decline (regression, deterioration in school or work performance, impaired dexterity and memory, speech difficulties, dementia, and lethargy) that is frequently described in the absence of other manifestations [<a class="bk_pop" href="#cbl.REF.powers.2001.396">Powers et al 2001</a>, <a class="bk_pop" href="#cbl.REF.boxer.2005.1431">Boxer et al 2005</a>, <a class="bk_pop" href="#cbl.REF.benomran.2007.979">Ben-Omran et al 2007</a>, <a class="bk_pop" href="#cbl.REF.thauvinrobinet.2008.725">Thauvin-Robinet et al 2008</a>]</div><div class="half_rhythm">Brain MRI may reveal leukodystrophy ranging from <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> periventricular white matter hyperintensities to diffuse white matter loss [<a class="bk_pop" href="#cbl.REF.rossi.2001.554">Rossi et al 2001</a>, <a class="bk_pop" href="#cbl.REF.longo.2005.366">Longo et al 2005</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Subacute combined degeneration of the spinal cord [<a class="bk_pop" href="#cbl.REF.bodamer.2001.1113">Bodamer et al 2001</a>, <a class="bk_pop" href="#cbl.REF.benomran.2007.979">Ben-Omran et al 2007</a>, <a class="bk_pop" href="#cbl.REF.tsai.2007.2430">Tsai et al 2007</a>]. In some cases, improvement has been reported after initiation of treatment [<a class="bk_pop" href="#cbl.REF.thauvinrobinet.2008.725">Thauvin-Robinet et al 2008</a>].</div></li></ul><p>Other presenting concerns in adolescents and adults have included renal thromobotic microangiopathy, HUS, pulmonary hypertension, and pulmonary thrombotic events [<a class="bk_pop" href="#cbl.REF.huemer.2014.161">Huemer et al 2014</a>].</p></div><div id="cbl.cblX_and_Related_Types_Disorders_of"><h4><i>cblX</i> and Related Types: Disorders of Transcriptional Regulation</h4><p>Newly identified disorders of intracellular cobalamin metabolism can have the biochemical features of <i>cblC</i> but are often clinically distinct with a more severe neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. These disorders include the <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder <i>cblX</i> and a similar phenotype (found in two individuals) associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in either <i>THAP11</i> or <i>ZNF143</i> [<a class="bk_pop" href="#cbl.REF.yu.2013.506">Yu et al 2013</a>, <a class="bk_pop" href="#cbl.REF.pupavac.2016.976">Pupavac et al 2016</a>, <a class="bk_pop" href="#cbl.REF.quintana.2017.2838">Quintana et al 2017</a>].</p><p>Individuals have presented with signs from the prenatal period (IUGR, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> malformations) to age five months (developmental delay, seizures). The developmental delay has been characterized as severe with significant intellectual disability and is associated with early-onset intractable seizures including infantile spasms. Microcephaly, brain malformations, and <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features were noted in some individuals. Other clinical features include nonketotic hyperglycinemia [<a class="bk_pop" href="#cbl.REF.scalais.2017.65">Scalais et al 2017</a>] and congenital malformations [<a class="bk_pop" href="#cbl.REF.g_rard.2015.148">G&#x000e9;rard et al 2015</a>].</p><p>Some expected metabolite abnormalities were mild enough to be difficult to detect. Abnormal metabolites responded to B<sub>12</sub> therapy, but clinical manifestations did not.</p></div><div id="cbl.cblF_and_cblJ_Types_Disorders_of_Lys"><h4><i>cblF</i> and <i>cblJ</i> Types: Disorders of Lysosomal Cobalamin Transport</h4><p><b><i>cblF.</i></b> Individuals with <i>cblF</i> often present during infancy with symptoms similar to <i>cblC &#x02013;</i> IUGR, poor postnatal growth, feeding difficulties, and developmental delay &#x02013; but can also have stomatitis with or without glossitis and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart malformations [<a class="bk_pop" href="#cbl.REF.alfadhel.2011.2571">Alfadhel et al 2011</a>]. Additional features such as cleft palate, unilateral renal agenesis, hepatic ductopenia, and intraventricular hemorrhage have also been described [<a class="bk_pop" href="#cbl.REF.gailus.2010.17">Gailus et al 2010</a>, <a class="bk_pop" href="#cbl.REF.constantinou.2016.254">Constantinou et al 2016</a>].</p><p><b><i>cblJ.</i></b> Only five individuals with <i>cblJ</i> have been reported. Three presented neonatally with poor growth, feeding problems, respiratory distress, bone marrow suppression, and cardiac defect [<a class="bk_pop" href="#cbl.REF.coelho.2012.1152">Coelho et al 2012</a>, <a class="bk_pop" href="#cbl.REF.fettelschoss.2017.11980">Fettelschoss et al 2017</a>] and two in early childhood with hyperpigmentation and premature graying; one of the two had a transient ischemic attack [<a class="bk_pop" href="#cbl.REF.kim.2012.664">Kim et al 2012</a>, <a class="bk_pop" href="#cbl.REF.takeichi.2015.1111">Takeichi et al 2015</a>]. Retinopathy was described in one individual in early childhood [<a class="bk_pop" href="#cbl.REF.fettelschoss.2017.11980">Fettelschoss et al 2017</a>].</p><p>Note: <i>cblF</i> and <i>cblJ</i> can in some cases be distinguished from <i>cblC</i> and <i>cblD</i>-combined because the former present with low serum B<sub>12</sub> levels.</p></div><div id="cbl.Isolated_Homocystinuria_cblE_cblG_cb"><h4>Isolated Homocystinuria (<i>cblE</i>, <i>cblG</i>, <i>cblD</i>-Homocystinuria)</h4><p>Methylcobalamin deficiency secondary to methionine synthase reductase deficiency (<i>cblE</i>), methionine synthase deficiency (<i>cblG</i>), and <i>cblD</i>-homocystinuria are rare syndromes that are not identified on <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a>, resulting in a delayed diagnosis [<a class="bk_pop" href="#cbl.REF.huemer.2015a.957">Huemer et al 2015a</a>].</p><p><b><i>cblE</i>.</b> Most children with <i>cblE</i> present in the first two years of life with severe growth failure, megaloblastic anemia, and neurologic manifestations; <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> megaloblastic anemia and HUS [<a class="bk_pop" href="#cbl.REF.palanca.2013.57">Palanca et al 2013</a>] may also be seen. Presentation in adolescence with atypical glomerulopathy has also been described [<a class="bk_pop" href="#cbl.REF.paul.2013.1135">Paul et al 2013</a>].</p><p><b><i>cblG</i>.</b> Individuals with <i>cblG</i> characteristically present in the first year of life with neurologic manifestations and megaloblastic anemia; however, phenotypic variability ranges from infantile to adult presentation. Neurologic manifestations may include weakness, hypotonia, seizures, mental status changes, and adult-onset leukoencephalopathy. Other unusual presentations of adult-onset <i>cblG</i> include megaloblastic anemia and progressive weakness (initially diagnosed as multiple sclerosis) [<a class="bk_pop" href="#cbl.REF.carmel.1988.1738">Carmel et al 1988</a>], neuropsychiatric illness [<a class="bk_pop" href="#cbl.REF.hill.2004.116">Hill et al 2004</a>], and thromobotic microangiopathy and atypical HUS [<a class="bk_pop" href="#cbl.REF.vaisbich.2017.1089">Vaisbich et al 2017</a>]. Optic nerve atrophy, nystagmus, and strabismus have been described [<a class="bk_pop" href="#cbl.REF.poloschek.2005.497">Poloschek et al 2005</a>, <a class="bk_pop" href="#cbl.REF.huemer.2015a.957">Huemer et al 2015a</a>].</p><p><b><i>cblD</i>-homocystinuria.</b> Individuals with <i>cblD</i>-homocystinuria (<a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylcobalamin deficiency) had cognitive impairment, neurologic signs, and megaloblastic anemia [<a class="bk_pop" href="#cbl.REF.suormala.2004.42742">Suormala et al 2004</a>]. Thromboembolic complications including clinically significant thrombophilia causing renal artery thrombosis [<a class="bk_pop" href="#cbl.REF.watkins.1989.427">Watkins &#x00026; Rosenblatt 1989</a>], HUS, and pulmonary hypertension [<a class="bk_pop" href="#cbl.REF.labrune.1999.734">Labrune et al 1999</a>] have also been described.</p></div></div><div id="cbl.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Genotype-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations observed include the following:</p><p><b><i>cblC</i></b></p><ul><li class="half_rhythm"><div>Infantile-presentation (early-onset), severe disease is associated with the <i>MMACHC</i> pathogenic variants <a class="figpopup" href="/books/NBK1328/table/cbl.T.mmachc_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figcblTmmachcpathogenicvariantsdiscuss" rid-ob="figobcblTmmachcpathogenicvariantsdiscuss">c.271dupA</a> or <a class="figpopup" href="/books/NBK1328/table/cbl.T.mmachc_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figcblTmmachcpathogenicvariantsdiscuss" rid-ob="figobcblTmmachcpathogenicvariantsdiscuss">c.331C&#x0003e;T</a> in the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> state.</div></li><li class="half_rhythm"><div>Noninfantile presentation (late onset) is usually associated with <i>MMACHC</i> pathogenic variants <a class="figpopup" href="/books/NBK1328/table/cbl.T.mmachc_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figcblTmmachcpathogenicvariantsdiscuss" rid-ob="figobcblTmmachcpathogenicvariantsdiscuss">c.394C&#x0003e;T</a> and <i>MMACHC</i>
<a class="figpopup" href="/books/NBK1328/table/cbl.T.mmachc_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figcblTmmachcpathogenicvariantsdiscuss" rid-ob="figobcblTmmachcpathogenicvariantsdiscuss">c.482G&#x0003e;A</a> [<a class="bk_pop" href="#cbl.REF.morel.2006.315">Morel et al 2006</a>, <a class="bk_pop" href="#cbl.REF.nogueira.2008.475">Nogueira et al 2008</a>, <a class="bk_pop" href="#cbl.REF.lernerellis.2009.1072">Lerner-Ellis et al 2009</a>, <a class="bk_pop" href="#cbl.REF.wang.2009.189">Wang et al 2009</a>, <a class="bk_pop" href="#cbl.REF.almannai.2017.60">Almannai et al 2017</a>]. It may also be associated with <i>MMACHC</i> variant <a class="figpopup" href="/books/NBK1328/table/cbl.T.mmachc_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figcblTmmachcpathogenicvariantsdiscuss" rid-ob="figobcblTmmachcpathogenicvariantsdiscuss">c.271dupA</a> if individuals are compound heterozygotes for <a class="figpopup" href="/books/NBK1328/table/cbl.T.mmachc_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figcblTmmachcpathogenicvariantsdiscuss" rid-ob="figobcblTmmachcpathogenicvariantsdiscuss">c.394C&#x0003e;T</a>, <a class="figpopup" href="/books/NBK1328/table/cbl.T.mmachc_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figcblTmmachcpathogenicvariantsdiscuss" rid-ob="figobcblTmmachcpathogenicvariantsdiscuss">c.347T&#x0003e;C</a>, <a class="figpopup" href="/books/NBK1328/table/cbl.T.mmachc_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figcblTmmachcpathogenicvariantsdiscuss" rid-ob="figobcblTmmachcpathogenicvariantsdiscuss">c.440 G&#x0003e;C</a>, or <a class="figpopup" href="/books/NBK1328/table/cbl.T.mmachc_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figcblTmmachcpathogenicvariantsdiscuss" rid-ob="figobcblTmmachcpathogenicvariantsdiscuss">c.482G&#x0003e;A</a> [<a class="bk_pop" href="#cbl.REF.morel.2006.315">Morel et al 2006</a>].</div></li></ul><p><b><i>cblD</i>.</b> The location of pathogenic variants within <i>MMADHC</i> correlates with the type of enzyme deficiency:</p><ul><li class="half_rhythm"><div><b>AdoCbl deficiency.</b> Typically, pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and frameshift variants are found in exons 3 and 4, encoding the region of the protein necessary for AdoCbl synthesis.</div></li><li class="half_rhythm"><div><b>MeCbl deficiency.</b> Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants are found in exons 6 and 8, encoding the C-terminal region of the protein necessary for MeCbl synthesis.</div></li><li class="half_rhythm"><div><b>AdoCbl and MeCbl deficiency.</b> Pathogenic variants occur in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 5, exon 8, and <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 7, encoding the middle of the protein [<a class="bk_pop" href="#cbl.REF.stucki.2012.1410">Stucki et al 2012</a>].</div></li></ul><p><b><i>cblE</i>,</b> caused by the <i>MTRR</i>
<a class="figpopup" href="/books/NBK1328/table/cbl.T.mtrr_pathogenic_variants_discussed/?report=objectonly" target="object" rid-figpopup="figcblTmtrrpathogenicvariantsdiscussed" rid-ob="figobcblTmtrrpathogenicvariantsdiscussed">c.1361C&#x0003e;T</a> (p.Ser545Leu) Iberian <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, has a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> than other reported pathogenic variants in <i>MTRR</i> with no evident neurologic involvement [<a class="bk_pop" href="#cbl.REF.zavad_kov_.2002.461">Zavad&#x000e1;kov&#x000e1; et al 2002</a>].</p><p>Clear <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have not been described for <i>cblF</i>, <i>cblG</i>, <i>cblJ</i>, or <i>cblX</i>.</p></div><div id="cbl.Prevalence"><h3>Prevalence</h3><p>The true prevalence of the disorders of intracellular cobalamin metabolism is unknown.</p><ul><li class="half_rhythm"><div>The incidence of <i>cblC</i> has been estimated at 1:200,000 births. Newborn screening suggested an incidence closer to 1:100,000 in New York State and 1:67,000 in California, where an incidence of 1:46,000 was estimated in the Hispanic population [<a class="bk_pop" href="#cbl.REF.cusmanoozog.2007.227">Cusmano-Ozog et al 2007</a>, <a class="bk_pop" href="#cbl.REF.weisfeldadams.2010.116">Weisfeld-Adams et al 2010</a>].</div></li><li class="half_rhythm"><div>Fewer than 40 cases have been described for <i>cblE</i> and <i>cblG</i>, and fewer than 20 cases each for <i>cblD</i>, <i>cblF</i>, <i>cblJ</i>, and <i>cblX</i> and its related types.</div></li></ul></div></div><div id="cbl.Genetically_Related_Allelic_Disorder"><h2 id="_cbl_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>ABCD4</i>, <i>LMBRD1</i>, <i>MMACHC</i>, <i>MMADHC</i>, <i>MTR</i>, <i>MTRR</i>, <i>THAP11</i>, or <i>ZNF143</i>.</p><p><i>HCFC1</i> pathogenic variants can cause intellectual disability with or without <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> malformations, in the absence of the characteristic biochemical manifestations of cobalamin disorder [<a class="bk_pop" href="#cbl.REF.huang.2012.694">Huang et al 2012</a>, <a class="bk_pop" href="#cbl.REF.koufaris.2016.215">Koufaris et al 2016</a>].</p></div><div id="cbl.Differential_Diagnosis"><h2 id="_cbl_Differential_Diagnosis_">Differential Diagnosis</h2><p>The following disorders may cause clinical manifestations and laboratory abnormalities similar to those seen in disorders of intracellular cobalamin metabolism.</p><p><b>Disorders causing both methylmalonic acidemia and homocystinuria</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Vitamin B<sub>12</sub> deficiency.</b> Individuals with vitamin B<sub>12</sub> deficiency can have methylmalonic acidemia and homocystinuria, as can the newborns of mothers who have vitamin B<sub>12</sub> deficiency. To establish the diagnosis of vitamin B<sub>12</sub> deficiency, it is necessary to measure serum vitamin B<sub>12</sub> concentrations in both <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> newborns and their mothers.</div><div class="half_rhythm">B<sub>12</sub> deficiency can occur in a breastfed infant of a vegan mother and in an infant born to a mother with subclinical pernicious anemia. The mother may not necessarily have a very low serum concentration of vitamin B<sub>12</sub>. Maternal vitamin B<sub>12</sub> deficiency can result in elevated methylmalonic acid level in an infant with findings that range from severe encephalopathy [<a class="bk_pop" href="#cbl.REF.higginbottom.1978.317">Higginbottom et al 1978</a>, <a class="bk_pop" href="#cbl.REF.dror.2008.250">Dror &#x00026; Allen 2008</a>] to elevated propionylcarnitine detected by <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> (NBS) [<a class="bk_pop" href="#cbl.REF.chace.2001.2040">Chace et al 2001</a>].</div><div class="half_rhythm">Intramuscular replacement therapy to normalize vitamin B<sub>12</sub> serum concentration reverses the metabolic abnormality.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Imerslund Gr&#x000e4;sbeck syndrome</b> (OMIM <a href="https://omim.org/entry/261100" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">261100</a>). Features of this <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder may include poor cobalamin absorption, abnormal renal tubular protein reabsorption, and urinary tract malformations. The disorder is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in one of two genes that encode intrinsic factor receptor components: <i>CUBN</i> (encoding cubulin) and <i>AMN</i> (encoding amnionless) [<a class="bk_pop" href="#cbl.REF.gr_sbeck.2006.17">Gr&#x000e4;sbeck 2006</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Transcobalamin II deficiency</b> (OMIM <a href="https://omim.org/entry/275350" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">275350</a>). Transcobalamin II (TCII) is required for the movement of cobalamin from intestinal enterocytes into cells throughout the body. Transcobalamin II deficiency, a rare <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> condition associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>TCN2</i>, is characterized by the infantile onset of megaloblastic anemia, failure to thrive, neurologic disease, and immunologic disease. Serum cobalamin concentrations are generally normal with a reduced (untreated) unsaturated B<sub>12</sub> binding capacity and a reduced level of transcobalamin II (the latter detected by an immunoassay) [<a class="bk_pop" href="#cbl.REF.kaikov.1991.841">Kaikov et al 1991</a>, <a class="bk_pop" href="#cbl.REF.watkins.2014">Watkins &#x00026; Rosenblatt 2014</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Transcobalamin receptor deficiency,</b> also known as methylmalonic acidemia, TCblR type (OMIM <a href="https://omim.org/entry/613646" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613646</a>). Transcobalamin receptor deficiency is a defect in the cellular uptake of cobalamin bound to TCII. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> and associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> variants in <i>CD320</i>, often a common <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>. This disorder may be a common defect in cobalamin metabolism based on the <a class="def" href="/books/n/gene/glossary/def-item/allele-frequency/">allele frequency</a> in population databases (MAF 0.009), but few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been identified and the clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is not well described [<a class="bk_pop" href="#cbl.REF.quadros.2010.924">Quadros et al 2010</a>]. Affected individuals may be identified on NBS; metabolites may normalize with cobalamin therapy and some individuals are reported to be asymptomatic [<a class="bk_pop" href="#cbl.REF.hannahshmouni.2018.1411">Hannah-Shmouni et al 2018</a>; Authors, unpublished observations].</div></li></ul><p><b>Disorders causing primarily <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> homocystinuria</b></p><ul><li class="half_rhythm"><div><a href="/books/n/gene/homocystinuria/"><b>Cystathionine beta-synthase (CBS) deficiency</b></a> (classic homocystinuria) is a disorder of homocysteine catabolism with a Marfan syndrome-like <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, soft skin, lens dislocation, developmental delays / cognitive impairment, and thromboembolism. CBS deficiency is progressive with onset typically in childhood. Biochemically it is characterized by elevated serum concentration of methionine and decreased serum concentration of cysteine. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> and associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> variants in <i>CBS.</i></div></li><li class="half_rhythm"><div><b>Methylenetetrahydrofolate reductase (MTHFR) deficiency</b> (OMIM <a href="https://omim.org/entry/236250" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">236250</a>) is a defect in folate-dependent <a class="def" href="/books/n/gene/glossary/def-item/methylation/">methylation</a> pathways that results in diminished conversion of homocysteine to methionine. The biochemical hallmark is moderate homocystinuria with low to normal plasma methionine levels. In contrast to methionine biosynthetic defects like <i>cblE</i> and <i>cblG</i>, megaloblastic anemia does not occur. The clinical course is characterized by varying severity, cognitive impairment, and white matter disease [<a class="bk_pop" href="#cbl.REF.fenton.2001">Fenton et al 2001</a>]. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> and associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> variants in <i>MTHFR</i>.</div></li><li class="half_rhythm"><div><b>Mild homocystinuria</b> can result from folate deficiency or vitamin B<sub>12</sub> deficiency.</div></li></ul><p><b>Disorders causing primarily methylmalonic acidemia</b></p><ul><li class="half_rhythm"><div>Disorders associated with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia include methylmalonic acidemia due to pathogenic variants of methylmalonyl-CoA mutase (<i>MUT</i>), <i>cblA</i> (<i>MMAA</i>), and <i>cblB</i> (<i>MMAB</i>); <a href="/books/n/gene/sucla2-def/">SUCLA2 deficiency</a>; <i>cblD</i>-MMA (<i>MMADHC</i>); "benign methylmalonic acidemia" [<a class="bk_pop" href="#cbl.REF.sniderman.1999.675">Sniderman et al 1999</a>, <a class="bk_pop" href="#cbl.REF.martens.2002.219">Martens et al 2002</a>]; Reye-like syndrome [<a class="bk_pop" href="#cbl.REF.chang.2000.295">Chang et al 2000</a>]; and combined malonic and methylmalonic acidemia (CMAMMA; OMIM <a href="https://omim.org/entry/614265" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614265</a>) caused by <i>ACSF3</i> pathogenic variants [<a class="bk_pop" href="#cbl.REF.alfares.2011.602">Alfares et al 2011</a>, <a class="bk_pop" href="#cbl.REF.sloan.2011.883">Sloan et al 2011</a>].</div></li><li class="half_rhythm"><div>For a more detailed description of other entities with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia, see <a href="/books/n/gene/mma/">Isolated Methylmalonic Acidemia</a>.</div></li></ul></div><div id="cbl.Management"><h2 id="_cbl_Management_">Management</h2><div id="cbl.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with a disorder of intracellular cobalamin metabolism, the following evaluations are recommended.</p><p>In an unstable individual:</p><ul><li class="half_rhythm"><div>Serial metabolic evaluations of blood gases, electrolytes, glucose, ammonia, liver function, total and direct bilirubin, renal function, lactate dehydrogenase, plasma amino acids (methionine), plasma methylmalonic acid (MMA), and total plasma homocysteine (tHcy) to guide acute management until the individual stabilizes</div></li><li class="half_rhythm"><div>Complete blood count (CBC) with differential to evaluate for megaloblastic anemia or cytopenias</div></li><li class="half_rhythm"><div>Peripheral blood smear to evaluate for the presence of schistocytes, in the presence of other manifestations of hemolytic uremic syndrome (HUS)</div></li></ul><p>Once the individual becomes stable:</p><ul><li class="half_rhythm"><div>Clinical assessment of growth parameters, head circumference, ability to feed, developmental status, and neurologic status</div></li><li class="half_rhythm"><div>Laboratory assessment of nutritional status (electrolytes, albumin, prealbumin, plasma amino acids [with careful attention to methionine levels], vitamin levels [including thiamine and 25-hydroxyvitamin D], and trace minerals) and renal function; complete blood count to monitor for cytopenias</div></li><li class="half_rhythm"><div>Echocardiogram to screen for cardiac defects and cardiomyopathy [<a class="bk_pop" href="#cbl.REF.profitlich.2009.344">Profitlich et al 2009</a>, <a class="bk_pop" href="#cbl.REF.tanpaiboon.2013.33">Tanpaiboon et al 2013</a>]</div></li><li class="half_rhythm"><div>EEG and brain MRI in symptomatic individuals</div></li><li class="half_rhythm"><div>Ophthalmologic examination</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="cbl.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>A set of guidelines for the diagnosis and management of <i>cblC</i>, <i>cblD</i>, <i>cblE</i>, <i>cblF</i>, <i>cblG</i>, <i>cblJ</i>, and MTHFR deficiency have been published [<a class="bk_pop" href="#cbl.REF.huemer.2017.21">Huemer et al 2017</a>].</p><p>Early treatment with hydroxocobalamin injections improves survival and biochemical, hematologic, and microangiopathic symptoms in individuals with <i>cblC</i>. Both <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> (NBS) and early treatment are recommended by current guidelines [<a class="bk_pop" href="#cbl.REF.huemer.2015b.1007">Huemer et al 2015b</a>, <a class="bk_pop" href="#cbl.REF.huemer.2017.21">Huemer et al 2017</a>].</p><p>Institution of therapy during acute illness results in rapid improvement of clinical, biochemical, and hematologic manifestations in individuals with early- and late-onset <i>cblC</i> [<a class="bk_pop" href="#cbl.REF.bartholomew.1988.32">Bartholomew et al 1988</a>, <a class="bk_pop" href="#cbl.REF.rosenblatt.1997.528">Rosenblatt et al 1997</a>, <a class="bk_pop" href="#cbl.REF.bodamer.2001.1113">Bodamer et al 2001</a>, <a class="bk_pop" href="#cbl.REF.tomaske.2001.511">Tomaske et al 2001</a>, <a class="bk_pop" href="#cbl.REF.kind.2002.327">Kind et al 2002</a>, <a class="bk_pop" href="#cbl.REF.van_hove.2002.195">Van Hove et al 2002</a>, <a class="bk_pop" href="#cbl.REF.fowler.2008.350">Fowler et al 2008</a>].</p><div id="cbl.At_the_Time_of_Diagnosis"><h4>At the Time of Diagnosis</h4><p>Goals of treatment are to reduce toxic metabolites and avoid low methionine levels.</p><ul><li class="half_rhythm"><div>Parenteral hydroxocobalamin (OHCbl) is the mainstay of therapy and should be instituted <b>immediately</b> when a disorder of intracellular cobalamin metabolism is suspected clinically or following positive NBS for propionylcarnitine.</div></li><li class="half_rhythm"><div>Cyanocobalamin should not be used as it will not be effective in individuals with <i>cblC</i>.</div></li><li class="half_rhythm"><div>Avoid treating individuals with a low-protein diet and medical foods designed for the treatment of individuals with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> MMA because they contain no methionine, which can further reduce methionine level.</div></li><li class="half_rhythm"><div>Those with elevated total plasma homocysteine (tHcy) should also receive betaine (250 mg/kg/day) and folate or folinic acid. Betaine has a short effective half-life and should be given in divided doses (optimally divided into 3 or 4 doses per day). It can also be titrated to response while monitoring tHcy and plasma methionine.</div></li></ul></div><div id="cbl.Acute_Metabolic_Decompensation"><h4>Acute Metabolic Decompensation</h4><p>Although less common in the disorders of intracellular cobalamin metabolism than in <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> <a href="/books/n/gene/mma/">methylmalonic acidemia</a>, severe acidotic/ketotic crises due to profound methylmalonic acidemia can occur, in particular at presentation or if untreated. Such critically ill individuals should be managed in consultation with a metabolic specialist. MedicAlert<sup>&#x000ae;</sup> bracelets and emergency treatment protocols outlining fluid and electrolyte therapy should be available for all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p>Treatment includes volume replacement with isotonic solutions containing high (10%-12.5%) glucose to reverse catabolism, correction of metabolic acidosis with sodium bicarbonate, and prompt reintroduction of feedings &#x02013; preferably enterally, but parenterally if enteral route cannot be established. Parenteral hydroxocobalamin should be given immediately in the setting of an acute decompensation.</p></div><div id="cbl.Thromboembolic_Complications"><h4>Thromboembolic Complications</h4><p>Thromboembolic complications as a cause of mortality in <i>cblC</i> are likely associated with increasing plasma concentrations of tHcy [<a class="bk_pop" href="#cbl.REF.carrillocarrasco.2012.103">Carrillo-Carrasco &#x00026; Venditti 2012</a>]. The proper management of thromboembolic complications, such as HUS and thrombotic microangiopathy, should include initiation (or dosage increase) of OHCbl and betaine [<a class="bk_pop" href="#cbl.REF.van_hove.2002.195">Van Hove et al 2002</a>, <a class="bk_pop" href="#cbl.REF.sharma.2007.2097">Sharma et al 2007</a>].</p></div><div id="cbl.LongTerm_Management"><h4>Long-Term Management</h4><p>The goals of long-term management include improving the metabolic derangement by lowering plasma tHcy and methylmalonic acid (MMA) concentrations and maintaining plasma methionine concentrations within the normal range. These are accomplished by the following.</p><p><b>Parenteral hydroxocobalamin (OHCbl).</b> The most experience derives from the treatment of individuals with <i>cblC</i>. Infants are usually started at a daily dose of 1.0 mg (~0.3 mg/kg/day) of OHCbl given intramuscularly or subcutaneously (SQ). Parenteral OHCbl (not the cyanocobalamin form or oral form) is the only effective preparation. Placement of a SQ catheter could be used to minimize cutaneous punctures [<a class="bk_pop" href="#cbl.REF.maines.2017.29">Maines et al 2017</a>]; prefilled injections may increase compliance.</p><p>Weight-appropriate adjustment of OHCbl to 0.3 mg/kg/day to maintain the dosing in infancy is recommended and can be attained by the ability to concentrate OHCbl up to 30 mg/mL [<a class="bk_pop" href="#cbl.REF.carrillocarrasco.2012.91">Carrillo-Carrasco et al 2012</a>]. Further titration of the dose may be empirically adjusted as needed for worsening clinical manifestations [<a class="bk_pop" href="#cbl.REF.van_hove.2002.195">Van Hove et al 2002</a>] or for metabolic control of plasma tHcy, MMA, or methionine [<a class="bk_pop" href="#cbl.REF.carrillocarrasco.2009.728">Carrillo-Carrasco et al 2009</a>]. Biochemical as well as clinical improvement has been demonstrated after increasing doses of OHCbl [<a class="bk_pop" href="#cbl.REF.matos.2013.360">Matos et al 2013</a>], although clinical trials are needed to demonstrate long-term clinical outcomes [<a class="bk_pop" href="#cbl.REF.dionisivici.2013.329">Dionisi-Vici et al 2013</a>].</p><p><b>Betaine.</b> Oral betaine (starting at ~250 mg/kg/day) is recommended in those with elevated plasma total homocysteine as it facilitates conversion of homocysteine to methionine through betaine homocysteine methyltransferase.</p><p><b>Folate and folinic acid.</b> Folic acid and folinic acid can potentially augment remethylation and may help improve plasma tHcy and methionine concentrations. Folinic acid may be preferred as it crosses the blood-brain barrier more efficiently than folic acid. The adult dose of folate is 1.0 mg by mouth per day, titratable down to 0.5 mg for maintenance. Doses for children and infants are available in the Harriet Lane Handbook [<a class="bk_pop" href="#cbl.REF.tschudy.2012">Tschudy &#x00026; Arcara 2012</a>] and other common reference texts.</p><p><b>Dietary management.</b> Individuals may be able to tolerate a normal diet.</p><ul><li class="half_rhythm"><div>Low-protein diets and medical foods designed for <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia are <b>not</b> recommended [<a class="bk_pop" href="#cbl.REF.huemer.2017.21">Huemer et al 2017</a>] as they can result in hypomethioninemia, which can be detrimental [<a class="bk_pop" href="#cbl.REF.ribes.1990.412">Ribes et al 1990</a>, <a class="bk_pop" href="#cbl.REF.rossi.2001.554">Rossi et al 2001</a>, <a class="bk_pop" href="#cbl.REF.de_bie.2009.266">De Bie et al 2009</a>].</div><ul><li class="half_rhythm"><div>The use of low-protein diets correlated with lower height-for-age z-scores [<a class="bk_pop" href="#cbl.REF.manoli.2016.396">Manoli et al 2016</a>], and intake of medical foods (methionine-free formulas) was associated with decreased head circumference in two cohorts of individuals with <i>cblC</i> [<a class="bk_pop" href="#cbl.REF.manoli.2016.396">Manoli et al 2016</a>, <a class="bk_pop" href="#cbl.REF.ahrensnicklas.2017.926">Ahrens-Nicklas et al 2017</a>].</div></li><li class="half_rhythm"><div>Medical foods designed for <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia do not contain methionine and also have an increased amount of leucine, which may compete with methionine for uptake to the brain and potentially exacerbate cerebral methionine deficiency.</div></li></ul></li><li class="half_rhythm"><div>Gastrostomy tube placement may be required in the presence of feeding difficulties and failure to thrive.</div></li></ul></div><div id="cbl.Other_Therapeutic_Considerations"><h4>Other Therapeutic Considerations</h4><p>The following have not been fully validated:</p><ul><li class="half_rhythm"><div><b>Methionine supplementation.</b> Hypomethioninemia is usually responsive to appropriate treatment with OHCbl, betaine, and optimal dietary management. The need for exogenous methionine supplementation may be minimized by these strategies, as the efficacy of this therapy is uncertain [<a class="bk_pop" href="#cbl.REF.smith.2006.138">Smith et al 2006</a>].</div></li><li class="half_rhythm"><div><b>Pyridoxine.</b> Vitamin B<sub>6</sub> is a cofactor for <a href="/books/n/gene/homocystinuria/">cystathionine beta-synthase</a> and therefore has been proposed as a means of maximizing the removal of homocysteine. Persons with disorders of intracellular cobalamin metabolism generally do not respond to pyridoxine unless they have a dietary deficiency.</div></li><li class="half_rhythm"><div><b>Levocarnitine.</b> Indicated for low plasma carnitine levels. Most individuals take 50-200 mg/kg/day to aid in the removal of excess propionyl-CoA groups.</div></li><li class="half_rhythm"><div><b>Metanx.</b> A supplement that contains L-methylfolate (active form of folate), methylcobalamin, and pyridoxal-5'-phosphate (active form of vitamin B<sub>6</sub>) is prescribed as a treatment for neuropathy. It may be used in individuals with cobalamin disorders (in particular teens and adults with clinical indication for neuropathy) and also considered in all individuals with cobalamin disorders to replace individual folate and B<sub>6</sub> supplements.</div></li><li class="half_rhythm"><div><b>Aspirin.</b> Antiplatelet doses of aspirin may be given to individuals with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> homocystinuria to decrease the risk for thrombosis [<a class="bk_pop" href="#cbl.REF.brunelguitton.2010.s409">Brunel-Guitton et al 2010</a>].</div></li></ul><p>Treatment of infantile spasms, seizures, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart malformations, and hydrocephalus is done in a routine manner.</p></div><div id="cbl.Prenatal_Therapy"><h4>Prenatal Therapy</h4><p>Prenatal therapy of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetus by administration of intramuscular OHCbl to the mother may improve neurocognitive outcome; however, the ophthalmologic manifestations are often still present [<a class="bk_pop" href="#cbl.REF.patton.2000.151">Patton et al 2000</a>, <a class="bk_pop" href="#cbl.REF.huemer.2005.469">Huemer et al 2005</a>, <a class="bk_pop" href="#cbl.REF.brooks.2016.571">Brooks et al 2016</a>, <a class="bk_pop" href="#cbl.REF.trefz.2016.55">Trefz et al 2016</a>].</p><ul><li class="half_rhythm"><div>The dose and frequency of OHCbl administration to pregnant mothers has not been established.</div></li><li class="half_rhythm"><div>Favorable outcomes of prenatal treatment have been reported by using dosages between 1 and 10 mg per day, 2-3 times a week, starting as early as 15 weeks' gestational age [<a class="bk_pop" href="#cbl.REF.huemer.2005.469">Huemer et al 2005</a>, <a class="bk_pop" href="#cbl.REF.trefz.2016.55">Trefz et al 2016</a>].</div></li></ul></div></div><div id="cbl.Prevention_of_Primary_Manifestations"><h3>Prevention of Primary Manifestations</h3><p>Early institution of injectable hydroxocobalamin improves survival and may reduce but not completely prevent primary manifestations.</p><p>To prevent metabolic decompensations, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals should be advised to avoid situations that result in catabolism, such as prolonged fasting and dehydration, and always remain on a weight-appropriate dose of hydroxocobalamin. Of note, during an intercurrent illness individuals may be treated with glucose-containing IV fluid.</p><p>Flu prevention (i.e., immunization) should be a routine part of health maintenance.</p></div><div id="cbl.Surveillance"><h3>Surveillance</h3><p>The following evaluations are performed at different intervals depending on age and disease severity:</p><ul><li class="half_rhythm"><div>During the first year of life, infants may need to be evaluated once or twice a month by a metabolic specialist.</div></li><li class="half_rhythm"><div>Toddlers and school-age children should be evaluated at least twice a year to adjust medication dosing (hydroxocobalamin, betaine) during growth and to evaluate nutritional status.</div></li><li class="half_rhythm"><div>Teens and adults may be seen on a yearly basis.</div></li></ul><p>Clinical evaluation should assess the following:</p><ul><li class="half_rhythm"><div>Growth including weight, linear growth, and head circumference</div></li><li class="half_rhythm"><div>Nutritional status</div></li><li class="half_rhythm"><div>Feeding ability</div></li><li class="half_rhythm"><div>Developmental and neurocognitive progress, as age-appropriate</div></li></ul><p>Laboratory evaluation should include the following:</p><ul><li class="half_rhythm"><div>Metabolic studies including urine organic acids, serum methylmalonic acid analysis, plasma amino acids (methionine), plasma tHcy concentration</div></li><li class="half_rhythm"><div>CBC to monitor for cytopenias</div></li><li class="half_rhythm"><div>Nutritional studies, if indicated: electrolytes, albumin, prealbumin, plasma amino acids, vitamin levels (including thiamine and 25-hydroxyvitamin D), essential fatty acids, and trace minerals</div></li></ul><p>Routine evaluations should include the following:</p><ul><li class="half_rhythm"><div>Ophthalmologic evaluation for retinal and optic nerve changes in those with <i>cblC</i> and <i>cblG</i> and if visual symptoms are present. Recommendations for the ophthalmologic follow up of individuals with <i>cblC</i> and related disorders have been published [<a class="bk_pop" href="#cbl.REF.weisfeldadams.2015.537">Weisfeld-Adams et al 2015</a>].</div></li><li class="half_rhythm"><div>Neurologic evaluations for early signs of developmental delays, behavioral disturbances, seizures, and myelopathy</div></li><li class="half_rhythm"><div>Brain MRI and/or EEG as clinically indicated</div></li><li class="half_rhythm"><div>Echocardiogram</div></li></ul></div><div id="cbl.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Potentially exacerbating circumstances:</p><ul><li class="half_rhythm"><div>Prolonged fasting (longer than overnight without dextrose-containing intravenous fluids)</div></li><li class="half_rhythm"><div>Dietary protein intake below the recommended dietary allowance (RDA) for age</div></li><li class="half_rhythm"><div>Dietary protein intake greater than that prescribed by a metabolic specialist especially in individuals with <i>cblC</i>, <i>cblD</i>-combined, <i>cblF</i>, or <i>cblJ</i></div></li><li class="half_rhythm"><div>Medical foods. Medical foods given to infants with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> methylmalonic acidemia do not contain methionine and should be avoided as the decreased methionine intake may worsen hypomethioninemia and long-term use may contribute to poor head and linear growth [<a class="bk_pop" href="#cbl.REF.manoli.2016.396">Manoli et al 2016</a>, <a class="bk_pop" href="#cbl.REF.ahrensnicklas.2017.926">Ahrens-Nicklas et al 2017</a>], among other complications.</div></li><li class="half_rhythm"><div>Nitrous oxide, an anesthetic that is potentially toxic as it depletes the body stores of vitamin B<sub>12</sub> and inhibits methionine synthase activity [<a class="bk_pop" href="#cbl.REF.kondo.1981.1270">Kondo et al 1981</a>, <a class="bk_pop" href="#cbl.REF.abels.1990.128">Abels et al 1990</a>, <a class="bk_pop" href="#cbl.REF.drummond.1994.3742">Drummond &#x00026; Matthews 1994</a>, <a class="bk_pop" href="#cbl.REF.baum.2007.824">Baum 2007</a>]</div></li></ul></div><div id="cbl.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the family are known, at-risk sibs may be tested prenatally to allow initiation of treatment in utero or as soon as possible after birth.</p><p>If the newborn sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has not undergone prenatal testing, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be performed in the first week of life if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the family are known. If the pathogneic variant(s) are not known, evaluation of urine organic acids and plasma amino acids, measurement of total plasma homocysteine, serum methylmalonic acid analysis, and acylcarnitine profile analysis can be used for the purpose of early diagnosis and treatment.</p><p>See <a href="#cbl.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cbl.Pregnancy_Management"><h3>Pregnancy Management</h3><p>A good pregnancy outcome was reported in two women with <i>cblC</i> [<a class="bk_pop" href="#cbl.REF.brunelguitton.2010.s409">Brunel-Guitton et al 2010</a>, <a class="bk_pop" href="#cbl.REF.liu.2015.286">Liu et al 2015</a>]. In addition, an unaffected infant was born to an asymptomatic woman with <i>cblC</i> who was diagnosed following her child's positive NBS for low carnitine [<a class="bk_pop" href="#cbl.REF.lin.2009.924">Lin et al 2009</a>].</p></div><div id="cbl.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="cbl.Genetic_Counseling"><h2 id="_cbl_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cbl.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Disorders of intracellular cobalamin metabolism caused by pathogenic variants in <i>ABCD4</i>, <i>LMBRD1</i>, <i>MMACHC</i>, <i>MMADHC</i>, <i>MTR</i>, <i>MTRR</i>, <i>THAP11</i>, or <i>ZNF143</i> are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p>The disorder of intracellular cobalamin metabolism caused by pathogenic variants in <i>HCFC1</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p><p>A single report of a deceased child with a paternally inherited <i>LMBRD1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and a maternally inherited <i>MTR</i> pathogenic variant suggests that <a class="def" href="/books/n/gene/glossary/def-item/digenic/">digenic</a> inheritance may also be possible [<a class="bk_pop" href="#cbl.REF.farwell_gonzalez.2015.29">Farwell Gonzalez et al 2015</a>].</p></div><div id="cbl.Risk_to_Family_Members__Autosomal_Re"><h3>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with a disorder of intracellular cobalamin metabolism are obligate heterozygotes (carriers) for an <i>ABCD4</i>, <i>LMBRD1</i>, <i>MMACHC</i>, <i>MMADHC</i>, <i>MTR</i>, <i>MTRR</i>, <i>THAP11</i>, or <i>ZNF143</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>ABCD4</i>, <i>LMBRD1</i>, <i>MMACHC</i>, <i>MMADHC</i>, <i>MTR</i>, <i>MTRR</i>, <i>THAP11</i>, or <i>ZNF143</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><div id="cbl.Carrier_Heterozygote_Detection"><h4>Carrier (Heterozygote) Detection</h4><p>Molecular genetic <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk relatives requires prior identification of the <i>ABCD4</i>, <i>LMBRD1</i>, <i>MMACHC</i>, <i>MMADHC</i>, <i>MTR</i>, <i>MTRR</i>, <i>THAP11</i>, or <i>ZNF143</i> pathogenic variants in the family.</p><p>Biochemical testing is not reliable for <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> detection.</p></div></div><div id="cbl.Risk_to_Family_Members__XLinked_Inhe"><h3>Risk to Family Members &#x02013; X-Linked Inheritance</h3><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disorder, nor will he be hemizyous for the <i>HCFC1</i> variant, and he does not require further evaluation/testing.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>). Note: If a woman has more than one affected child and no other affected relatives and if the <i>HCFC1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she most likely has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>If a male is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case), the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> or the affected male may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>HCFC1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, in which case the mother is not a heterozygote (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>). Because very few families with <i>HCFC1</i> pathogenic variants have been described, the frequency of <i>de novo</i> pathogenic variants is not known.</div></li></ul><p><b>Sibs of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the mother.</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has an <i>HCFC1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Females who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and will usually not be affected (no affected females have been described to date).</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <i>HCFC1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Affected males transmit the <i>HCFC1</i> variant to:</p><ul><li class="half_rhythm"><div>All of their daughters, who will be carriers (heterozygotes) and will usually not be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; and</div></li><li class="half_rhythm"><div>None of their sons.</div></li></ul><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal aunts may be at risk of being heterozygotes (carriers) for the <i>HCFC1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, and the aunts' offspring, depending on their gender, may be at risk of being heterozygotes for the pathogenic variant (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females) or of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> (males).</p><div id="cbl.Carrier_Heterozygote_Detection_1"><h4>Carrier (Heterozygote) Detection</h4><p>Molecular genetic <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk relatives requires prior identification of the <i>HCFC1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family. Note: Females who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> (carriers) for this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder will usually not be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p>Biochemical testing is not reliable for <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a>.</p></div></div><div id="cbl.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#cbl.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cbl.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, molecular genetic prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p><b>Biochemical testing.</b> If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have not been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for pregnancies at risk for a disorder of intracellular cobalamin metabolism may be possible using these methods:</p><ul><li class="half_rhythm"><div>Complementation analysis of cultured amniocytes [<a class="bk_pop" href="#cbl.REF.morel.2005.160">Morel et al 2005</a>, <a class="bk_pop" href="#cbl.REF.watkins.2014">Watkins &#x00026; Rosenblatt 2014</a>]</div></li><li class="half_rhythm"><div>Measurement of MMA and tHcy concentrations in amniotic fluid using mass spectrometric techniques [<a class="bk_pop" href="#cbl.REF.morel.2005.160">Morel et al 2005</a>, <a class="bk_pop" href="#cbl.REF.watkins.2014">Watkins &#x00026; Rosenblatt 2014</a>].</div></li></ul></div></div><div id="cbl.Resources"><h2 id="_cbl_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>HCU Network America</b></div><div>623 Creek Lane</div><div>Flourtown PA 19031</div><div><b>Phone:</b> 630-360-2087</div><div><b>Email:</b> hcunetworkamerica@gmail.com</div><div><a href="https://hcunetworkamerica.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hcunetworkamerica.org</a></div></li><li class="half_rhythm"><div><b>Organic Acidemia Association</b></div><div><b>Phone:</b> 763-559-1797</div><div><b>Fax:</b> 866-539-4060 (toll-free)</div><div><b>Email:</b> kstagni@oaanews.org; menta@oaanews.org</div><div><a href="http://www.oaanews.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.oaanews.org</a></div></li><li class="half_rhythm"><div><b>European Network and Registry for Homocystinurias and Methylation Defects (E-HOD)</b></div><div><a href="http://www.e-hod.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.e-hod.org</a></div></li></ul></div><div id="cbl.Molecular_Genetics"><h2 id="_cbl_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cbl.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Disorders of Intracellular Cobalamin Metabolism: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1328/table/cbl.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cbl.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cbl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cbl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cbl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cbl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cbl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cbl.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cbl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5826" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ABCD4</i></a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5826" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">14q24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O14678" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATP-binding cassette sub-family D member 4</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cbl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ABCD4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ABCD4</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ABCD4[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ABCD4</a></td></tr><tr><td headers="hd_b_cbl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3054" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>HCFC1</i></a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3054" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xq28</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P51610" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Host cell factor 1</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/HCFC1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HCFC1 @ LOVD</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HCFC1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HCFC1</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=HCFC1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HCFC1</a></td></tr><tr><td headers="hd_b_cbl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/55788" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>LMBRD1</i></a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=55788" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6q13</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9NUN5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Probable lysosomal cobalamin transporter</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/LMBRD1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LMBRD1 database</a><br /><a href="https://lovd.nl/LMBRD1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZJU-CGGM Database (LMBRD1)</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=LMBRD1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LMBRD1</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=LMBRD1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LMBRD1</a></td></tr><tr><td headers="hd_b_cbl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/25974" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MMACHC</i></a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=25974" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p34<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9Y4U1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Methylmalonic aciduria and homocystinuria type C protein</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/MMACHC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMACHC database</a><br /><a href="https://lovd.nl/MMACHC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZJU-CGGM Database (MMACHC)</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MMACHC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMACHC</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MMACHC[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMACHC</a></td></tr><tr><td headers="hd_b_cbl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/27249" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MMADHC</i></a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=27249" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q23<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9H3L0" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Methylmalonic aciduria and homocystinuria type D protein, mitochondrial</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://proteomics.bio21.unimelb.edu.au/lovd/genes/MMADHC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMADHC @ LOVD</a><br /><a href="https://lovd.nl/MMADHC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZJU-CGGM Database (MMADHC)</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MMADHC" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMADHC</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MMADHC[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MMADHC</a></td></tr><tr><td headers="hd_b_cbl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4548" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MTR</i></a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4548" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q43</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q99707" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Methionine synthase</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/MTR" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MTR @ LOVD</a><br /><a href="https://lovd.nl/MTR" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZJU-CGGM Database (MTR)</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MTR" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MTR</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MTR[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MTR</a></td></tr><tr><td headers="hd_b_cbl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4552" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MTRR</i></a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4552" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5p15<wbr style="display:inline-block"></wbr>​.31</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9UBK8" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Methionine synthase reductase</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/MTRR" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MTRR @ LOVD</a><br /><a href="https://lovd.nl/MTRR" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZJU-CGGM Database (MTRR)</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MTRR" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MTRR</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MTRR[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MTRR</a></td></tr><tr><td headers="hd_b_cbl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/57215" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>THAP11</i></a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=57215" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">16q22<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q96EK4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">THAP domain-containing protein 11</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cbl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=THAP11" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">THAP11</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=THAP11[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">THAP11</a></td></tr><tr><td headers="hd_b_cbl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7702" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ZNF143</i></a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7702" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11p15<wbr style="display:inline-block"></wbr>​.4</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P52747" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Zinc finger protein 143</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_b_cbl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ZNF143" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZNF143</a></td><td headers="hd_b_cbl.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ZNF143[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ZNF143</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cbl.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cbl.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Disorders of Intracellular Cobalamin Metabolism (<a href="/omim/156570,236270,250940,277380,277400,277410,300019,309541,602568,603214,603433,609119,609831,611935,612625" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1328/table/cbl.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cbl.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/156570" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">156570</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">5-@METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; MTR</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/236270" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">236270</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE; HMAE</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/250940" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">250940</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE; HMAG</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/277380" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">277380</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE; MAHCF</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/277400" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">277400</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/277410" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">277410</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE; MAHCD</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300019" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300019</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HOST CELL FACTOR C1; HCFC1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/309541" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">309541</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602568" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602568</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METHIONINE SYNTHASE REDUCTASE; MTRR</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603214" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603214</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 4; ABCD4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603433" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603433</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ZINC FINGER PROTEIN 143; ZNF143</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609119" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609119</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">THAP DOMAIN-CONTAINING PROTEIN 11; THAP11</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609831" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609831</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">METABOLISM OF COBALAMIN ASSOCIATED C; MMACHC</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611935" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611935</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MMADHC GENE; MMADHC</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612625" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612625</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LMBR1 DOMAIN-CONTAINING PROTEIN 1: LMBRD1</td></tr></tbody></table></div></div><p>See <a class="figpopup" href="/books/NBK1328/figure/cbl.F1/?report=objectonly" target="object" rid-figpopup="figcblF1" rid-ob="figobcblF1">Figure1</a>. For detailed summaries of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information for the genes discussed in this section, see <a href="/books/NBK1328/#cbl.molgen.TA">Table A</a>, <b>Gene</b>.</p><div id="cbl.ABCD4"><h3><i>ABCD4</i></h3><p><b>Gene structure.</b> The longest transcript variant of <i>ABCD4</i> is 3,157 bp with 19 exons (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005050.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005050.3</a>) [<a class="bk_pop" href="#cbl.REF.holzinger.1998.238">Holzinger et al 1998</a>]. Alternative <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> results in multiple transcript variants.</p><p><b>Pathogenic variants.</b> Missense, frameshift, and <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variants have been reported [<a class="bk_pop" href="#cbl.REF.coelho.2012.1152">Coelho et al 2012</a>, <a class="bk_pop" href="#cbl.REF.kim.2012.664">Kim et al 2012</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The ABCD4 protein contains 606 amino acids (<a href="/protein/NP_005041.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005041.1</a>) and has a mass of 73 kd [<a class="bk_pop" href="#cbl.REF.shani.1997.1925">Shani et al 1997</a>]. It is an ATP-binding cassette (ABC) transporter that colocalizes with lysosomal proteins LAMP1 and LMBRD1 (<i>cblF</i>). It is thought that its ATPase activity may be involved in the intracellular processing of cobalamin [<a class="bk_pop" href="#cbl.REF.coelho.2012.1152">Coelho et al 2012</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants are expected to affect the lysosomal transport of cobalamin into the cytoplasm [<a class="bk_pop" href="#cbl.REF.coelho.2012.1152">Coelho et al 2012</a>].</p></div><div id="cbl.HCFC1"><h3><i>HCFC1</i></h3><p><b>Gene structure.</b>
<i>HCFC1</i> is a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> of about 24 kb; it comprises 26 exons.</p><p><b>Pathogenic variants.</b> Five <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants were identified in 14 individuals with <i>cblX</i>: c.202C&#x0003e;G, c.217G&#x0003e;A, c.218C&#x0003e;T, c.343G&#x0003e;A, and c.344C&#x0003e;T [<a class="bk_pop" href="#cbl.REF.yu.2013.506">Yu et al 2013</a>]. These variants were located in the first two Kelch domains, which are conserved ~50-amino-acid sequences that interact to form a &#x003b2;-propeller structure and are involved in protein-protein interactions. An additional variant, c.307T&#x0003e;C, was reported in another family [<a class="bk_pop" href="#cbl.REF.g_rard.2015.148">G&#x000e9;rard et al 2015</a>].</p><p>Other <i>HCFC1</i> variants have been reported in individuals with intellectual disability with or without <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> malformations, in the absence of known biochemical abnormalities (although biochemical testing has not always been performed) [<a class="bk_pop" href="#cbl.REF.huang.2012.694">Huang et al 2012</a>, <a class="bk_pop" href="#cbl.REF.jolly.2015.3335">Jolly et al 2015</a>, <a class="bk_pop" href="#cbl.REF.koufaris.2016.215">Koufaris et al 2016</a>].</p><p>Variants listed in <a class="figpopup" href="/books/NBK1328/table/cbl.T.hcfc1_variants_discussed_in_this_g/?report=objectonly" target="object" rid-figpopup="figcblThcfc1variantsdiscussedinthisg" rid-ob="figobcblThcfc1variantsdiscussedinthisg">Table 5</a> are only those <i>HCFC1</i> variants reported to cause a cobalamin disorder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><div id="cbl.T.hcfc1_variants_discussed_in_this_g" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>HCFC1</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1328/table/cbl.T.hcfc1_variants_discussed_in_this_g/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cbl.T.hcfc1_variants_discussed_in_this_g_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.202C&#x0003e;G</td><td headers="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln68Glu</td><td headers="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_3" rowspan="6" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005334.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005334<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_005325.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005325<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.217G&#x0003e;A</td><td headers="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala73Thr</td></tr><tr><td headers="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.218C&#x0003e;T</td><td headers="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala73Val</td></tr><tr><td headers="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.307T&#x0003e;C</td><td headers="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr103His</td></tr><tr><td headers="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.343G&#x0003e;A</td><td headers="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala115Thr</td></tr><tr><td headers="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.344C&#x0003e;T</td><td headers="hd_h_cbl.T.hcfc1_variants_discussed_in_this_g_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala115Val</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>HCFC1</i> encodes host cell factor C-1 (aka HCF-1), a transcriptional coregulator. The protein is 2,035 amino acids long and is known to interact with transcription factors including those encoded by <i>THAP11</i> and <i>ZNF143</i>. The HCFC1 complex has been reported to regulate hundreds of genes [<a class="bk_pop" href="#cbl.REF.dejosez.2010.1479">Dejosez et al 2010</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Fibroblasts from individuals with p.Ala73Val and p.Ala115Val showed decreased <i>MMACHC</i> RNA and protein expression, suggesting the failure of mutated HCFC1 protein to regulate <i>MMACHC</i> expression &#x02013; potentially the result of disrupted protein-protein interactions via the Kelch domains.</p></div><div id="cbl.LMBRD1"><h3><i>LMBRD1</i></h3><p><b>Gene structure.</b>
<i>LMBRD1</i> is a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> of 121 kb; it comprises 16 exons [<a class="bk_pop" href="#cbl.REF.rutsch.2009.234">Rutsch et al 2009</a>].</p><p><b>Pathogenic variants.</b>
<a class="bk_pop" href="#cbl.REF.rutsch.2009.234">Rutsch et al [2009]</a> studied 12 unrelated individuals with <i>cblF</i> confirmed by complementation analysis. A common variant, c.1056delG, was seen in 18/24 independent alleles; this variant causes a frameshift yielding a premature stop codon in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 11 [<a class="bk_pop" href="#cbl.REF.rutsch.2009.234">Rutsch et al 2009</a>]. Altogether five different DNA variants accounted for 22 of 24 observed pathogenic variants. Eight additional variants have been reported including small deletions, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants, and a large (6-kb) <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, the latter described by <a class="bk_pop" href="#cbl.REF.miousse.2011.505">Miousse et al [2011]</a>.</p><div id="cbl.T.lmbrd1_pathogenic_variants_discuss" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p><i>LMBRD1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1328/table/cbl.T.lmbrd1_pathogenic_variants_discuss/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cbl.T.lmbrd1_pathogenic_variants_discuss_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cbl.T.lmbrd1_pathogenic_variants_discuss_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cbl.T.lmbrd1_pathogenic_variants_discuss_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cbl.T.lmbrd1_pathogenic_variants_discuss_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cbl.T.lmbrd1_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1056delG</td><td headers="hd_h_cbl.T.lmbrd1_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn353IlefsTer18</td><td headers="hd_h_cbl.T.lmbrd1_pathogenic_variants_discuss_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_018368.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_018368<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_060838.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_060838<wbr style="display:inline-block"></wbr>​.3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The probable lysosomal cobalamin transporter LMBR1 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>-containing one protein (LMBD1) is 540 amino acids and has a predicted molecular weight of 61.3 kd (the longest isoform). The predicted protein structure includes nine transmembrane regions and multiple potential glycosylation sites. The protein has been shown by immunocytofluorescence to colocalize with the lysosomal marker LAMP1. The protein is predicted to be a lysosomal membrane transporter [<a class="bk_pop" href="#cbl.REF.rutsch.2009.234">Rutsch et al 2009</a>] and interacts in a complex with ABCD4 (<i>cblJ</i>) [<a class="bk_pop" href="#cbl.REF.fettelschoss.2017.11980">Fettelschoss et al 2017</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants cause the defective release of cobalamin from lysosomes.</p></div><div id="cbl.MMACHC"><h3><i>MMACHC</i></h3><p><b>Gene structure.</b>
<i>MMACHC</i> is 11 kb and comprises four exons [<a class="bk_pop" href="#cbl.REF.lernerellis.2006.93">Lerner-Ellis et al 2006</a>].</p><p><b>Pathogenic variants.</b> More than 90 variants have been identified in persons with <i>cblC</i>. <a class="figpopup" href="/books/NBK1328/table/cbl.T.mmachc_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figcblTmmachcpathogenicvariantsdiscuss" rid-ob="figobcblTmmachcpathogenicvariantsdiscuss">Table 7</a> includes variants common in certain populations, such as c.609G&#x0003e;A, which is common in individuals of Chinese ancestry. The most common variant, present in an estimated 30%-50% of alleles, is c.271dupA, historically associated with infantile-onset disease.</p><div id="cbl.T.mmachc_pathogenic_variants_discuss" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p><i>MMACHC</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1328/table/cbl.T.mmachc_pathogenic_variants_discuss/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cbl.T.mmachc_pathogenic_variants_discuss_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change&#x000a0;<sup>1</sup></th><th id="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.271dupA&#x000a0;<sup>2</sup></td><td headers="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg91LysfsTer140</td><td headers="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_3" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_015506.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_015506<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/NP_056321.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_056321<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.331C&#x0003e;T&#x000a0;<sup>3</sup></td><td headers="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg111Ter</td></tr><tr><td headers="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.347T&#x0003e;C</td><td headers="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu116Pro</td></tr><tr><td headers="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.394C&#x0003e;T&#x000a0;<sup>4</sup></td><td headers="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg132Ter</td></tr><tr><td headers="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.440G&#x0003e;C</td><td headers="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly147Ala</td></tr><tr><td headers="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.482G&#x0003e;A&#x000a0;<sup>5</sup></td><td headers="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg161Gln</td></tr><tr><td headers="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.609G&#x0003e;A&#x000a0;<sup>6</sup></td><td headers="hd_h_cbl.T.mmachc_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp203Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="cbl.TF.7.1"><p class="no_margin">See <a href="#cbl.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>.</p></div></dd><dt>2. </dt><dd><div id="cbl.TF.7.2"><p class="no_margin">Accounts for approximately 30%-50% of disease alleles in individuals of European ancestry [<a class="bk_pop" href="#cbl.REF.lernerellis.2006.93">Lerner-Ellis et al 2006</a>, <a class="bk_pop" href="#cbl.REF.lernerellis.2009.1072">Lerner-Ellis et al 2009</a>, <a class="bk_pop" href="#cbl.REF.fischer.2014.831">Fischer et al 2014</a>]</p></div></dd><dt>3. </dt><dd><div id="cbl.TF.7.3"><p class="no_margin">Common in people of Cajun and French Canadian ancestry [<a class="bk_pop" href="#cbl.REF.lernerellis.2009.1072">Lerner-Ellis et al 2009</a>]</p></div></dd><dt>4. </dt><dd><div id="cbl.TF.7.4"><p class="no_margin">Common in people of Indian and Middle Eastern ancestry [<a class="bk_pop" href="#cbl.REF.lernerellis.2009.1072">Lerner-Ellis et al 2009</a>]; associated with a late-onset <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></p></div></dd><dt>5. </dt><dd><div id="cbl.TF.7.5"><p class="no_margin">Associated with milder disease, and may be more common in individuals of Hispanic descent [<a class="bk_pop" href="#cbl.REF.almannai.2017.60">Almannai et al 2017</a>]</p></div></dd><dt>6. </dt><dd><div id="cbl.TF.7.6"><p class="no_margin">Common in people of Chinese ancestry [<a class="bk_pop" href="#cbl.REF.liu.2010.621">Liu et al 2010</a>]</p></div></dd></dl></div></div></div><p>Recently, three individuals who are double <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for pathogenic variants in <i>MMACHC</i> and <i>PRDX1</i> have been identified. <i>PRDX1</i> is a neighboring <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 1 transcribed from the reverse strand. Variants identified in <i>PRDX1</i> located at the <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 5 splice acceptor site caused skipping of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 6, transcription of antisense <i>MMACHC</i>, and hypermethylation of the <i>MMACHC</i> promoter/exon 1, resulting in no gene expression from that <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#cbl.REF.gu_ant.2018.554">Gu&#x000e9;ant et al 2018</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The methylmalonic aciduria and homocystinuria type C (MMACHC) protein has 282 amino acids and a predicted molecular weight of 31.7 kd. The MMACHC protein has been crystallized and in vitro studies have shown that MMACHC removes the upper B-axial ligand of cobalamin derivatives (e.g., CN, OH, Ado, Me) through dealkylation or decyanation using glutathione; it is also thought to be involved in intracellular trafficking of cobalamins [<a class="bk_pop" href="#cbl.REF.koutmos.2011.29780">Koutmos et al 2011</a>]. MMACHC resides in a complex with MMADHC and other proteins in the pathway [<a class="bk_pop" href="#cbl.REF.gherasim.2013.1023">Gherasim et al 2013</a>, <a class="bk_pop" href="#cbl.REF.bassila.2017.103">Bassila et al 2017</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Defects in MMACHC disrupt its ability to process newly internalized cobalamins in the cytosol [<a class="bk_pop" href="#cbl.REF.hannibal.2009.260">Hannibal et al 2009</a>].</p></div><div id="cbl.MMADHC"><h3><i>MMADHC</i></h3><p><b>Gene structure.</b>
<i>MMADHC</i>, previously known as <i>C2orf25</i>, is 18 kb and comprises eight exons (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_015702.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_015702.2</a>) [<a class="bk_pop" href="#cbl.REF.coelho.2008.1454">Coelho et al 2008</a>].</p><p><b>Pathogenic variants.</b> There are no clearly identified common disease-causing variants; 13 variants have been reported to date. Pathogenic variants in <i>MMADHC</i> can result in three different phenotypes &#x02013; <i>cblD</i>-MMA (AdoCbl deficiency), <i>cblD</i>-Hcy (MeCbl deficiency), and <i>cblD</i>-combined (AdoCbl and MeCbl deficiency). The pathogenic variants described to date are either <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> or truncating (<a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, splice, or frameshift) variants.</p><ul><li class="half_rhythm"><div>Truncating variants in exons 3 and 4, encoding the N-terminus of the protein, cause AdoCbl deficiency (<i>cblD</i>-MMA) [<a class="bk_pop" href="#cbl.REF.coelho.2008.1454">Coelho et al 2008</a>, <a class="bk_pop" href="#cbl.REF.plesa.2011.139">Plesa et al 2011</a>, <a class="bk_pop" href="#cbl.REF.stucki.2012.1410">Stucki et al 2012</a>].</div></li><li class="half_rhythm"><div>Missense variants in exons 6 and 8, encoding the C-terminus, cause MeCbl deficiency (<i>cblD</i>-Hcy) [<a class="bk_pop" href="#cbl.REF.coelho.2008.1454">Coelho et al 2008</a>, <a class="bk_pop" href="#cbl.REF.stucki.2012.1410">Stucki et al 2012</a>].</div></li><li class="half_rhythm"><div>Truncating variants in exons 5, 7, and 8 and <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 7 cause combined AdoCbl and MeCbl deficiency [<a class="bk_pop" href="#cbl.REF.coelho.2008.1454">Coelho et al 2008</a>, <a class="bk_pop" href="#cbl.REF.stucki.2012.1410">Stucki et al 2012</a>].</div></li></ul><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <i>MMADHC</i> product is predicted to have 296 amino acids with a calculated molecular mass of 32.8 kd (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_056517.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_056517.1</a>) [<a class="bk_pop" href="#cbl.REF.stucki.2012.1410">Stucki et al 2012</a>]. There is an N-terminal mitochondrial leader sequence [<a class="bk_pop" href="#cbl.REF.coelho.2008.1454">Coelho et al 2008</a>]. The C-terminus is thought to guide vitamin B<sub>12</sub> to methionine synthase [<a class="bk_pop" href="#cbl.REF.plesa.2011.139">Plesa et al 2011</a>]. In vitro studies suggest that MMADHC does not directly bind cobalamin but may act as a chaperone given that it binds to MMACHC [<a class="bk_pop" href="#cbl.REF.deme.2012.352">Deme et al 2012</a>, <a class="bk_pop" href="#cbl.REF.gherasim.2013.1023">Gherasim et al 2013</a>]. The crystal structure showed that MMADHC is a modified nitroreductase fold with structural similarity to MMACHC [<a class="bk_pop" href="#cbl.REF.froese.2015.29167">Froese et al 2015</a>, <a class="bk_pop" href="#cbl.REF.yamada.2015.29155">Yamada et al 2015</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The type and location of pathogenic variants within the protein is thought to determine whether the synthesis of AdoCbl, MeCbl, or both is affected. Variants in the region encoding the mitochondrial targeting sequence (amino acid position 1-61) affect AdoCbl synthesis.</p></div><div id="cbl.MTR"><h3><i>MTR</i></h3><p><b>Gene structure.</b>
<i>MTR</i> is 105.24 kb and comprises 33 exons [<a class="bk_pop" href="#cbl.REF.brody.1999.324">Brody et al 1999</a>].</p><p><b>Pathogenic variants.</b> About 40 pathogenic variants have been identified. The most common disease-causing <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> in persons with <i>cblG</i> is a <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant, c.3518C&#x0003e;T, accounting for 40% of alleles [<a class="bk_pop" href="#cbl.REF.watkins.2002.143">Watkins et al 2002</a>].</p><p>A subset of severe pathogenic variants (including frameshifting deletions and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants) [<a class="bk_pop" href="#cbl.REF.watkins.2002.143">Watkins et al 2002</a>] and a variant resulting in a cryptic <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> are thought to result in premature translation termination and <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> instability [<a class="bk_pop" href="#cbl.REF.wilson.1998.409">Wilson et al 1998</a>, <a class="bk_pop" href="#cbl.REF.watkins.2002.143">Watkins et al 2002</a>].</p><p><a class="bk_pop" href="#cbl.REF.leclerc.1996.1867">Leclerc et al [1996]</a> identified two pathogenic variants specifically near the cobalamin-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>.</p><div id="cbl.T.mtr_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 8. </span></h3><div class="caption"><p><i>MTR</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1328/table/cbl.T.mtr_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cbl.T.mtr_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cbl.T.mtr_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cbl.T.mtr_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cbl.T.mtr_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cbl.T.mtr_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3518C&#x0003e;T</td><td headers="hd_h_cbl.T.mtr_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro1173Leu</td><td headers="hd_h_cbl.T.mtr_pathogenic_variants_discussed_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000254.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000254<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/NP_000245.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000245<wbr style="display:inline-block"></wbr>​.2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The MTR enzyme has 1,265 amino acids and weighs 140.5 kd. There are at least three functional domains:</p><ul><li class="half_rhythm"><div>The 38-kd C-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> binds AdoMet.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> comprising amino acids 650 to 896 includes the binding domain for the required cofactor methylcobalamin.</div></li><li class="half_rhythm"><div>The 70-kd N-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> binds homocysteine and methyltetrahydrofolate.</div></li></ul><p>The latter two activities may be on separate domains within this region [<a class="bk_pop" href="#cbl.REF.goulding.1997.8082">Goulding et al 1997</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants are expected to decrease enzymatic activity.</p></div><div id="cbl.MTRR"><h3><i>MTRR</i></h3><p><b>Gene structure.</b> The longest transcript variant of <i>MTRR</i> (<a href="/nuccore/NM_002454.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_002454.2</a>) comprises 15 exons and encodes the shorter protein isoform of 698 amino acids (<a href="/protein/NP_002445.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_002445.2</a>). In comparison, the transcript variant <a href="/nuccore/NM_024010.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_024010.2</a> uses an alternate <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> in the 5' region and initiates translation at an alternate start codon. The encoded protein isoform <a href="/protein/NP_076915.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_076915.2</a> has 725 amino acids with a longer N-terminus.</p><p><b>Pathogenic variants.</b> More than 25 variants in <i>MTRR</i> have been reported.</p><ul><li class="half_rhythm"><div>The most common disease-causing variant, accounting for 25% of alleles, is a deep <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> variant in <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 6 (c.903+469T&#x0003e;C) that activates a splice enhancer site in a pseudoexon resulting in its inclusion [<a class="bk_pop" href="#cbl.REF.zavad_kov_.2002.461">Zavad&#x000e1;kov&#x000e1; et al 2002</a>, <a class="bk_pop" href="#cbl.REF.zavad_kov_.2005.239">Zavad&#x000e1;kov&#x000e1; et al 2005</a>, <a class="bk_pop" href="#cbl.REF.homolova.2010.437">Homolova et al 2010</a>].</div></li><li class="half_rhythm"><div>The c.1361C&#x0003e;T variant is common in persons of Iberian ancestry. Reports suggest a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with no neurologic involvement [<a class="bk_pop" href="#cbl.REF.zavad_kov_.2005.239">Zavad&#x000e1;kov&#x000e1; et al 2005</a>].</div></li></ul><p>Other variants have been described [<a class="bk_pop" href="#cbl.REF.leclerc.1999.75">Leclerc et al 1999</a>, <a class="bk_pop" href="#cbl.REF.zavad_kov_.2002.461">Zavad&#x000e1;kov&#x000e1; et al 2002</a>]. Most reported variants have been nonconservative <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants.</p><div id="cbl.T.mtrr_pathogenic_variants_discussed" class="table"><h3><span class="label">Table 9. </span></h3><div class="caption"><p><i>MTRR</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1328/table/cbl.T.mtrr_pathogenic_variants_discussed/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cbl.T.mtrr_pathogenic_variants_discussed_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cbl.T.mtrr_pathogenic_variants_discussed_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change (Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_cbl.T.mtrr_pathogenic_variants_discussed_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cbl.T.mtrr_pathogenic_variants_discussed_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cbl.T.mtrr_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.903+469T&#x0003e;C<br />(903_904ins140)</td><td headers="hd_h_cbl.T.mtrr_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_cbl.T.mtrr_pathogenic_variants_discussed_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_002454.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_002454<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/NP_002445.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_002445<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_cbl.T.mtrr_pathogenic_variants_discussed_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1361C&#x0003e;T</td><td headers="hd_h_cbl.T.mtrr_pathogenic_variants_discussed_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser545Leu</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="cbl.TF.9.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The MTRR protein isoform <a href="/protein/NP_002445.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_002445.2</a> has 698 amino acids. MTRR shares homology with human cytochrome P450 reductase [<a class="bk_pop" href="#cbl.REF.leclerc.1999.75">Leclerc et al 1999</a>]. MTRR has some chaperone-like activity with regard to MTR [<a class="bk_pop" href="#cbl.REF.yamada.2006.9476">Yamada et al 2006</a>]. The longer N-terminus isoform <a href="/protein/NP_076915.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_076915.2</a> was initially predicted to have a mitochondrial leader sequence [<a class="bk_pop" href="#cbl.REF.leclerc.1999.75">Leclerc et al 1999</a>], but in vitro experiments suggest that the protein is primarily cytosolic [<a class="bk_pop" href="#cbl.REF.froese.2008.68">Froese et al 2008</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants are expected to decrease enzymatic activity.</p></div><div id="cbl.THAP11"><h3><i>THAP11</i></h3><p><b>Gene structure.</b> The <i>THAP11</i> transcript <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_020457.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020457.2</a> is ~2 kb and contains a single <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>.</p><p><b>Pathogenic variants.</b> A single variant, <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_020457.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020457.2</a>:c.240C&#x0003e;G (p.Phe80Leu), was identified in the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> state in a single individual with a <i>cblX</i>-like clinical and biochemical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#cbl.REF.quintana.2017.2838">Quintana et al 2017</a>].</p><div id="cbl.T.thap11_variants_discussed_in_this" class="table"><h3><span class="label">Table 10. </span></h3><div class="caption"><p><i>THAP11</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1328/table/cbl.T.thap11_variants_discussed_in_this/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cbl.T.thap11_variants_discussed_in_this_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cbl.T.thap11_variants_discussed_in_this_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cbl.T.thap11_variants_discussed_in_this_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cbl.T.thap11_variants_discussed_in_this_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cbl.T.thap11_variants_discussed_in_this_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.240C&#x0003e;G</td><td headers="hd_h_cbl.T.thap11_variants_discussed_in_this_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe80Leu</td><td headers="hd_h_cbl.T.thap11_variants_discussed_in_this_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_020457.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020457<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_065190.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_065190<wbr style="display:inline-block"></wbr>​.2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>).See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The transcript (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_020457" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020457</a>) encodes a 314-amino-acid protein (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_065190.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_065190.2</a>). THAP11 (THAP containing protein 11) is a <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> located in a complex with HCFC1, ZNF143, and other proteins that regulate the expression of hundreds of genes including <i>MMACHC</i>.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The variant reported may interfere with DNA binding or disrupt the interactions with HCFC1, ZNF143, and other proteins in the complex, resulting in decreased expression of <i>MMACHC</i> and other genes.</p></div><div id="cbl.ZNF143"><h3><i>ZNF143</i></h3><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is 67 kb and is composed of 16 exons.</p><p><b>Pathogenic variants.</b> The two variants shown in <a class="figpopup" href="/books/NBK1328/table/cbl.T.znf143_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figcblTznf143variantsdiscussedinthis" rid-ob="figobcblTznf143variantsdiscussedinthis">Table 11</a> have been reported in a single case [<a class="bk_pop" href="#cbl.REF.pupavac.2016.976">Pupavac et al 2016</a>].</p><div id="cbl.T.znf143_variants_discussed_in_this" class="table"><h3><span class="label">Table 11. </span></h3><div class="caption"><p><i>ZNF143</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1328/table/cbl.T.znf143_variants_discussed_in_this/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cbl.T.znf143_variants_discussed_in_this_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cbl.T.znf143_variants_discussed_in_this_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cbl.T.znf143_variants_discussed_in_this_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cbl.T.znf143_variants_discussed_in_this_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ReferenceSequences</th></tr></thead><tbody><tr><td headers="hd_h_cbl.T.znf143_variants_discussed_in_this_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.851T&#x0003e;G</td><td headers="hd_h_cbl.T.znf143_variants_discussed_in_this_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu284Ter</td><td headers="hd_h_cbl.T.znf143_variants_discussed_in_this_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_003442.5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003442<wbr style="display:inline-block"></wbr>​.5</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_003433.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_003433<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_cbl.T.znf143_variants_discussed_in_this_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1019C&#x0003e;T</td><td headers="hd_h_cbl.T.znf143_variants_discussed_in_this_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr340Ile</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>).See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The longest transcript is 2.9 kb (<a href="/nuccore/NM_003442" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003442</a>) encoding a protein of 638 amino acids. ZNF143 is a <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> located in a complex with HCFC1, THAP11, and other proteins that regulate the expression of hundreds of genes.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The variants reported may interfere with DNA binding or disrupt the interactions with HCFC1, ZNF143, and other proteins in the complex, resulting in decreased expression of <i>MMACHC</i> and other genes.</p></div></div><div id="cbl.References"><h2 id="_cbl_References_">References</h2><div id="cbl.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.abels.1990.128">Abels J, Kroes AC, Ermens AA, van Kapel J, Schoester M, Spijkers LJ, Lindemans J. Anti-leukemic potential of methyl-cobalamin inactivation by nitrous oxide. <span><span class="ref-journal">Am J Hematol. </span>1990;<span class="ref-vol">34</span>:128–31.</span> [<a href="/pubmed/2187335" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2187335</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.ahrensnicklas.2015.71">Ahrens-Nicklas RC, Serdaroglu E, Muraresku C, Ficicioglu C. Cobalamin C disease missed by newborn screening in a patient with low carnitine level. <span><span class="ref-journal">JIMD Rep. </span>2015;<span class="ref-vol">23</span>:71–75.</span> [<a href="/pmc/articles/PMC4484904/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4484904</span></a>] [<a href="/pubmed/25772322" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25772322</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.ahrensnicklas.2017.926">Ahrens-Nicklas RC, Whitaker AM, Kaplan P, Cuddapah S, Burfield J, Blair J, Brochi L, Yudkoff M, Ficicioglu C. Efficacy of early treatment in patients with cobalamin C disease identified by newborn screening: a 16-year experience. <span><span class="ref-journal">Genet Med. </span>2017;<span class="ref-vol">19</span>:926–35.</span> [<a href="/pmc/articles/PMC6082364/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6082364</span></a>] [<a href="/pubmed/28151490" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28151490</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.alfadhel.2011.2571">Alfadhel M, Lillquist YP, Davis C, Junker AK, Stockler-Ipsiroglu S. Eighteen-year follow-up of a patient with cobalamin F disease (cblF): report and review. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:2571–7.</span> [<a href="/pubmed/21910240" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21910240</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.alfares.2011.602">Alfares A, Nunez LD, Al-Thihli K, Mitchell J, Melan&#x000e7;on S, Anastasio N, Ha KC, Majewski J, Rosenblatt DS, Braverman N. Combined malonic and methylmalonic aciduria: exome sequencing reveals mutations in the ACSF3 gene in patients with a non-classic phenotype. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:602–5.</span> [<a href="/pubmed/21785126" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21785126</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.almannai.2017.60">Almannai M, Marom R, Divin K, Scaglia F, Sutton VR, Craigen WJ, Lee B, Burrage LC, Graham BH. Milder clinical and biochemical phenotypes associated with the c.482G&#x0003e;A (p.Arg161Gln) pathogenic variant in cobalamin C disease: implications for management and screening. <span><span class="ref-journal">Mol Genet Metab. </span>2017;<span class="ref-vol">122</span>:60–6.</span> [<a href="/pmc/articles/PMC5612879/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5612879</span></a>] [<a href="/pubmed/28693988" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28693988</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.bartholomew.1988.32">Bartholomew DW, Batshaw ML, Allen RH, Roe CR, Rosenblatt D, Valle DL, Francomano CA. Therapeutic approaches to cobalamin-C methylmalonic acidemia and homocystinuria. <span><span class="ref-journal">J Pediatr. </span>1988;<span class="ref-vol">112</span>:32–9.</span> [<a href="/pubmed/3257264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3257264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.bassila.2017.103">Bassila C, Ghemrawi R, Flayac J, Froese DS, Baumgartner MR, Gu&#x000e9;ant JL, Coelho D. Methionine synthase and methionine synthase reductase interact with MMACHC and with MMADHC. <span><span class="ref-journal">Biochim Biophys Acta. </span>2017;<span class="ref-vol">1863</span>:103–12.</span> [<a href="/pubmed/27771510" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27771510</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.baum.2007.824">Baum VC. When nitrous oxide is no laughing matter: nitrous oxide and pediatric anesthesia. <span><span class="ref-journal">Paediatr Anaesth. </span>2007;<span class="ref-vol">17</span>:824–30.</span> [<a href="/pubmed/17683399" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17683399</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.beck.2017.733">Beck BB, van Spronsen F, Diepstra A, Berger RM, K&#x000f6;mhoff M. Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity. <span><span class="ref-journal">Pediatr Nephrol. </span>2017;<span class="ref-vol">32</span>:733–41.</span> [<a href="/pmc/articles/PMC5368212/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5368212</span></a>] [<a href="/pubmed/27289364" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27289364</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.benomran.2007.979">Ben-Omran TI, Wong H, Blaser S, Feigenbaum A. Late-onset cobalamin-C disorder: a challenging diagnosis. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:979–84.</span> [<a href="/pubmed/17431913" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17431913</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.bodamer.2001.1113">Bodamer OA, Rosenblatt DS, Appel SH, Beaudet AL. Adult-onset combined methylmalonic aciduria and homocystinuria (cblC). <span><span class="ref-journal">Neurology. </span>2001;<span class="ref-vol">56</span>:1113.</span> [<a href="/pubmed/11320193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11320193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.boxer.2005.1431">Boxer AL, Kramer JH, Johnston K, Goldman J, Finley R, Miller BL. Executive dysfunction in hyperhomocystinemia responds to homocysteine-lowering treatment. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:1431–4.</span> [<a href="/pubmed/15851736" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15851736</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.brandstetter.1990.167">Brandstetter Y, Weinhouse E, Splaingard ML, Tang TT. Cor pulmonale as a complication of methylmalonic acidemia and homocystinuria (Cbl-C type). <span><span class="ref-journal">Am J Med Genet. </span>1990;<span class="ref-vol">36</span>:167–71.</span> [<a href="/pubmed/2368803" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2368803</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.brody.1999.324">Brody LC, Baker PJ, Chines PS, Musick A, Molloy AM, Swanson DA, Kirke PN, Ghosh S, Scott JM, Mills JL. Methionine synthase: high-resolution mapping of the human gene and evaluation as a candidate locus for neural tube defects. <span><span class="ref-journal">Mol Genet Metab. </span>1999;<span class="ref-vol">67</span>:324–33.</span> [<a href="/pubmed/10444343" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10444343</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.brooks.2016.571">Brooks BP, Thompson AH, Sloan JL, Manoli I, Carrillo-Carrasco N, Zein WM, Venditti CP. Ophthalmic manifestations and long-term visual outcomes in patients with cobalamin C deficiency. <span><span class="ref-journal">Ophthalmology. </span>2016;<span class="ref-vol">123</span>:571–82.</span> [<a href="/pmc/articles/PMC5065014/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5065014</span></a>] [<a href="/pubmed/26825575" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26825575</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.brunelguitton.2010.s409">Brunel-Guitton C, Costa T, Mitchell GA, Lambert M. Treatment of cobalamin C (cblC) deficiency during pregnancy. <span><span class="ref-journal">J Inherit Metab Dis. </span>2010;<span class="ref-vol">33</span> Suppl 3:S409–12.</span> [<a href="/pubmed/20830523" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20830523</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.brunelli.2002.800">Brunelli SM, Meyers KE, Guttenberg M, Kaplan P, Kaplan BS. Cobalamin C deficiency complicated by an atypical glomerulopathy. <span><span class="ref-journal">Pediatr Nephrol. </span>2002;<span class="ref-vol">17</span>:800–3.</span> [<a href="/pubmed/12376806" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12376806</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.carmel.1988.1738">Carmel R, Watkins D, Goodman SI, Rosenblatt DS. Hereditary defect of cobalamin metabolism (cblG mutation) presenting as a neurologic disorder in adulthood. <span><span class="ref-journal">N Engl J Med. </span>1988;<span class="ref-vol">318</span>:1738–41.</span> [<a href="/pubmed/2897628" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2897628</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.carrillocarrasco.2012.91">Carrillo-Carrasco N, Chandler RJ, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management. <span><span class="ref-journal">J Inherit Metab Dis. </span>2012;<span class="ref-vol">35</span>:91–102.</span> [<a href="/pmc/articles/PMC4219318/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4219318</span></a>] [<a href="/pubmed/21748409" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21748409</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.carrillocarrasco.2009.728">Carrillo-Carrasco N, Sloan J, Valle D, Hamosh A, Venditti CP. Hydroxocobalamin dose escalation improves metabolic control in cblC. <span><span class="ref-journal">J Inherit Metab Dis. </span>2009;<span class="ref-vol">32</span>:728–31.</span> [<a href="/pmc/articles/PMC3479241/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3479241</span></a>] [<a href="/pubmed/19821145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19821145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.carrillocarrasco.2012.103">Carrillo-Carrasco N, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes. <span><span class="ref-journal">J Inherit Metab Dis. </span>2012;<span class="ref-vol">35</span>:103–14.</span> [<a href="/pmc/articles/PMC3529128/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3529128</span></a>] [<a href="/pubmed/21748408" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21748408</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.cerone.1999.247">Cerone R, Schiaffino MC, Caruso U, Lupino S, Gatti R. Minor facial anomalies in combined methylmalonic aciduria and homocystinuria due to a defect in cobalamin metabolism. <span><span class="ref-journal">J Inherit Metab Dis. </span>1999;<span class="ref-vol">22</span>:247–50.</span> [<a href="/pubmed/10384379" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10384379</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.chace.2001.2040">Chace DH, DiPerna JC, Kalas TA, Johnson RW, Naylor EW. Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns. <span><span class="ref-journal">Clin Chem. </span>2001;<span class="ref-vol">47</span>:2040–4.</span> [<a href="/pubmed/11673377" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11673377</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.chang.2000.295">Chang PF, Huang SF, Hwu WL, Hou JW, Ni YH, Chang MH. Metabolic disorders mimicking Reye's syndrome. <span><span class="ref-journal">J Formos Med Assoc. </span>2000;<span class="ref-vol">99</span>:295–9.</span> [<a href="/pubmed/10870312" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10870312</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.coelho.2012.1152">Coelho D, Kim JC, Miousse IR, Fung S, du Moulin M, Buers I, Suormala T, Burda P, Frapolli M, Stucki M, N&#x000fc;rnberg P, Thiele H, Robenek H, H&#x000f6;hne W, Longo N, Pasquali M, Mengel E, Watkins D, Shoubridge EA, Majewski J, Rosenblatt DS, Fowler B, Rutsch F, Baumgartner MR. Mutations in ABCD4 cause a new inborn error of vitamin B12 metabolism. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:1152–5.</span> [<a href="/pubmed/22922874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22922874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.coelho.2008.1454">Coelho D, Suormala T, Stucki M, Lerner-Ellis JP, Rosenblatt DS, Newbold RF, Baumgartner MR, Fowler B. Gene identification for the cblD defect of vitamin B12 metabolism. <span><span class="ref-journal">N Engl J Med. </span>2008;<span class="ref-vol">358</span>:1454–64.</span> [<a href="/pubmed/18385497" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18385497</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.constantinou.2016.254">Constantinou P, D'Alessandro M, Lochhead P, Samant S, Bisset WM, Hauptfleisch C, Dean J, et al.  A new, atypical case of cobalamin F disorder diagnosed by whole exome sequencing. <span><span class="ref-journal">Mol Syndromol. </span>2016;<span class="ref-vol">6</span>:254–8.</span> [<a href="/pmc/articles/PMC4772619/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4772619</span></a>] [<a href="/pubmed/26997947" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26997947</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.cusmanoozog.2007.227">Cusmano-Ozog K, Levine S, Martin M, Nicholas E, Packman S, Rosenblatt D, Cederbaum S, Cowan T, Enns G. Cobalamin C disease identified by newborn screening: the California experience. In: Program and abstracts for the SIMD annual meeting. <span><span class="ref-journal">Mol Genet Metab. </span>2007;<span class="ref-vol">90</span>:227–65.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.de_bie.2009.266">De Bie I, Nizard SD, Mitchell GA. Fetal dilated cardiomyopathy: an unsuspected presentation of methylmalonic aciduria and hyperhomocystinuria, cblC type. <span><span class="ref-journal">Prenat Diagn. </span>2009;<span class="ref-vol">29</span>:266–70.</span> [<a href="/pubmed/19248038" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19248038</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.dejosez.2010.1479">Dejosez M, Levine SS, Frampton GM, Whyte WA, Stratton SA, Barton MC, Gunaratne PH, Young RA, Zwaka TP. Ronin/Hcf-1 binds to a hyperconserved enhancer element and regulates genes involved in the growth of embryonic stem cells. <span><span class="ref-journal">Genes Dev. </span>2010;<span class="ref-vol">24</span>:1479–84.</span> [<a href="/pmc/articles/PMC2904937/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2904937</span></a>] [<a href="/pubmed/20581084" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20581084</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.deme.2012.352">Deme JC, Miousse IR, Plesa M, Kim JC, Hancock MA, Mah W, Rosenblatt DS, Coulton JW. Structural features of recombinant MMADHC isoforms and their interactions with MMACHC, proteins of mammalian vitamin B12 metabolism. <span><span class="ref-journal">Mol Genet Metab. </span>2012;<span class="ref-vol">107</span>:352–62.</span> [<a href="/pubmed/22832074" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22832074</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.dionisivici.2013.329">Dionisi-Vici C, Martinelli D, Ceravolo F, Boenzi S, Pastore A. Optimizing the dose of hydroxocobalamin in cobalamin C (cblC) defect. <span><span class="ref-journal">Mol Genet Metab. </span>2013;<span class="ref-vol">109</span>:329–30.</span> [<a href="/pubmed/23764205" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23764205</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.dror.2008.250">Dror DK, Allen LH. Effect of vitamin B12 deficiency on neurodevelopment in infants: current knowledge and possible mechanisms. <span><span class="ref-journal">Nutr Rev. </span>2008;<span class="ref-vol">66</span>:250–5.</span> [<a href="/pubmed/18454811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18454811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.drummond.1994.3742">Drummond JT, Matthews RG. Nitrous oxide inactivation of cobalamin-dependent methionine synthase from Escherichia coli: characterization of the damage to the enzyme and prosthetic group. <span><span class="ref-journal">Biochemistry. </span>1994;<span class="ref-vol">33</span>:3742–50.</span> [<a href="/pubmed/8142374" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8142374</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.farwell_gonzalez.2015.29">Farwell Gonzalez KD, Li X, Lu HM, Lu H, Pellegrino JE, Miller RT, Zeng W, Chao EC. Diagnostic exome sequencing and tailored bioinformatics of the parents of a deceased child with cobalamin deficiency suggests digenic inheritance of the MTR and LMBRD1 genes. <span><span class="ref-journal">JIMD Rep. </span>2015;<span class="ref-vol">15</span>:29–37.</span> [<a href="/pmc/articles/PMC4270861/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4270861</span></a>] [<a href="/pubmed/24664876" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24664876</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.fenton.2001">Fenton WA, Gravel RA, Rosenblatt DS. Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. <em>The Metabolic and Molecular Bases of Inherited Disease</em>. 8 ed. McGraw-Hill, NY; 2001:2165-93.</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.fettelschoss.2017.11980">Fettelschoss V, Burda P, Sagne C, Coelho D, De Laet C, Lutz S, Suormala T, Fowler B, Pietrancosta N, Gasnier B, Bornhauser B, Froese DS, Baumgartner MR. Clinical or ATPase domain mutations in ABCD4 disrupt the interaction between the vitamin B12-trafficking proteins ABCD4 and LMBD1. <span><span class="ref-journal">J Biol Chem. </span>2017;<span class="ref-vol">292</span>:11980–91.</span> [<a href="/pmc/articles/PMC5512089/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5512089</span></a>] [<a href="/pubmed/28572511" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28572511</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.fischer.2014.831">Fischer S, Huemer M, Baumgartner M, Deodato F, Ballhausen D, Boneh A, Burlina AB, Cerone R, Garcia P, Gokcay G, Grunewald S, Haberle J, Jaeken J, Ketteridge D, Lindner M, Mandel H, Martinelli D, Martins EG, Schwab KO, Gruenert SC, Schwahn BC, Sztriha L, Tomaske M, Trefz F, Vilarinho L, Rosenblatt DS, Fowler B, Dionisi-Vici C. Clinical presentation and outcome in a series of 88 patients with the cblC defect. <span><span class="ref-journal">J Inherit Metab Dis. </span>2014;<span class="ref-vol">37</span>:831–40.</span> [<a href="/pubmed/24599607" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24599607</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.fowler.2008.350">Fowler B, Leonard JV, Baumgartner MR. Causes of and diagnostic approach to methylmalonic acidurias. <span><span class="ref-journal">J Inherit Metab Dis. </span>2008;<span class="ref-vol">31</span>:350–60.</span> [<a href="/pubmed/18563633" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18563633</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.francis.2004.420">Francis PJ, Calver DM, Barnfield P, Turner C, Dalton RN, Champion MP. An infant with methylmalonic aciduria and homocystinuria (cblC) presenting with retinal haemorrhages and subdural haematoma mimicking non-accidental injury. <span><span class="ref-journal">Eur J Pediatr. </span>2004;<span class="ref-vol">163</span>:420–1.</span> [<a href="/pubmed/15221473" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15221473</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.frattini.2010.135">Frattini D, Fusco C, Ucchino V, Tavazzi B, Della Giustina E. Early onset methylmalonic aciduria and homocystinuria cblC type with demyelinating neuropathy. <span><span class="ref-journal">Pediatr Neurol. </span>2010;<span class="ref-vol">43</span>:135–8.</span> [<a href="/pubmed/20610126" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20610126</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.froese.2015.29167">Froese DS, Kopec J, Fitzpatrick F, Schuller M, McCorvie TJ, Chalk R, Plessl T, Fettelschoss V, Fowler B, Baumgartner MR, Yue WW. Structural insights into the MMACHC-MMADHC protein complex involved in vitamin B12 trafficking. <span><span class="ref-journal">J Biol Chem. </span>2015;<span class="ref-vol">290</span>:29167–77.</span> [<a href="/pmc/articles/PMC4705923/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4705923</span></a>] [<a href="/pubmed/26483544" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26483544</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.froese.2008.68">Froese DS, Wu X, Zhang J, Dumas R, Schoel WM, Amrein M, Gravel RA. Restricted role for methionine synthase reductase defined by subcellular localization. <span><span class="ref-journal">Mol Genet Metab. </span>2008;<span class="ref-vol">94</span>:68–77.</span> [<a href="/pmc/articles/PMC2765244/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2765244</span></a>] [<a href="/pubmed/18221906" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18221906</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.gaillard.2008.491">Gaillard MC, Matthieu JM, Borruat FX. Retinal dysfunction in combined methylmalonic aciduria and homocystinuria (Cblc) disease: a spectrum of disorders. <span><span class="ref-journal">Klin Monbl Augenheilkd. </span>2008;<span class="ref-vol">225</span>:491–4.</span> [<a href="/pubmed/18454408" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18454408</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.gailus.2010.17">Gailus S, Suormala T, Malerczyk-Aktas AG, Toliat MR, Wittkampf T, Stucki M, N&#x000fc;rnberg P, Fowler B, Hennermann JB, Rutsch F. A novel mutation in LMBRD1 causes the cblF defect of vitamin B(12) metabolism in a Turkish patient. <span><span class="ref-journal">J Inherit Metab Dis. </span>2010;<span class="ref-vol">33</span>:17–24.</span> [<a href="/pubmed/20127417" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20127417</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.geraghty.1992.934">Geraghty MT, Perlman EJ, Martin LS, Hayflick SJ, Casella JF, Rosenblatt DS, Valle D. Cobalamin C defect associated with hemolytic-uremic syndrome. <span><span class="ref-journal">J Pediatr. </span>1992;<span class="ref-vol">120</span>:934–7.</span> [<a href="/pubmed/1593355" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1593355</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.g_rard.2015.148">G&#x000e9;rard M, Morin G, Bourillon A, Colson C, Mathieu S, Rabier D, Billette de Villemeur T, Ogier de Baulny H, Benoist JF. Multiple congenital anomalies in two boys with mutation in HCFC1 and cobalamin disorder. <span><span class="ref-journal">Eur J Med Genet. </span>2015;<span class="ref-vol">58</span>:148–53.</span> [<a href="/pubmed/25595573" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25595573</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.gherasim.2013.1023">Gherasim C, Hannibal L, Rajagopalan D, Jacobsen DW, Banerjee R. The C-terminal domain of CblD interacts with CblC and influences intracellular cobalamin partitioning. <span><span class="ref-journal">Biochimie. </span>2013;<span class="ref-vol">95</span>:1023–32.</span> [<a href="/pmc/articles/PMC3657558/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3657558</span></a>] [<a href="/pubmed/23415655" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23415655</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.goulding.1997.8082">Goulding CW, Postigo D, Matthews RG. Cobalamin-dependent methionine synthase is a modular protein with distinct regions for binding homocysteine, methyltetrahydrofolate, cobalamin, and adenosylmethionine. <span><span class="ref-journal">Biochemistry. </span>1997;<span class="ref-vol">36</span>:8082–91.</span> [<a href="/pubmed/9201956" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9201956</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.gr_sbeck.2006.17">Gr&#x000e4;sbeck R. Imerslund-Gr&#x000e4;sbeck syndrome (selective vitamin B(12) malabsorption with proteinuria). <span><span class="ref-journal">Orphanet J Rare Dis. </span>2006;<span class="ref-vol">1</span>:17.</span> [<a href="/pmc/articles/PMC1513194/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1513194</span></a>] [<a href="/pubmed/16722557" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16722557</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.gu_ant.2018.554">Gu&#x000e9;ant JL, Chery C, Oussalah A, Nadaf J, Coelho D, Josse T, Flayac J, Robert A, Koscinski I, Gastin I, Filhine-Tresarrieu P, Pupavac M, Brebner A, Watkins D, Pastinen T, Montpetit A, Hariri F, Tregouet D, Raby BA, Chung WK, Morange PE, Froese DS, Baumgartner MR, Benoist JF, Ficicioglu C, Marchand V, Motorin Y, Bonnemains C, Feillet F, Majewski J, Rosenblatt DS. A. PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients. <span><span class="ref-journal">Nat Commun. </span>2018;<span class="ref-vol">9</span>:554.</span> [<a href="/pmc/articles/PMC5797229/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5797229</span></a>] [<a href="/pubmed/29396438" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29396438</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.guigonis.2005.588">Guigonis V, Fremeaux-Bacchi V, Giraudier S, Favier R, Borderie D, Massy Z, Mougenot B, Rosenblatt DS, Deschenes G. Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation. <span><span class="ref-journal">Am J Kidney Dis. </span>2005;<span class="ref-vol">45</span>:588–95.</span> [<a href="/pubmed/15754282" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15754282</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.hannahshmouni.2018.1411">Hannah-Shmouni F, Cruz V, Schulze A, Mercimek-Andrews S. Transcobalamin receptor defect: identification of two new cases through positive newborn screening for propionic/methylmalonic aciduria and long-term outcome. <span><span class="ref-journal">Am J Med Genet A. </span>2018;<span class="ref-vol">176</span>:1411–5.</span> [<a href="/pubmed/29663633" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29663633</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.hannibal.2009.260">Hannibal L, Kim J, Brasch NE, Wang S, Rosenblatt DS, Banerjee R, Jacobsen DW. Processing of alkylcobalamins in mammalian cells: a role for the MMACHC (cblC) gene product. <span><span class="ref-journal">Mol Genet Metab. </span>2009;<span class="ref-vol">97</span>:260–6.</span> [<a href="/pmc/articles/PMC2709701/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2709701</span></a>] [<a href="/pubmed/19447654" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19447654</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.harding.2003.384">Harding CO, Pillers DA, Steiner RD, Bottiglieri T, Rosenblatt DS, Debley J, Gibson MK. Potential for misdiagnosis due to lack of metabolic derangement in combined methylmalonic aciduria/hyperhomocysteinemia (cblC) in the neonate. <span><span class="ref-journal">J Perinatol. </span>2003;<span class="ref-vol">23</span>:384–6.</span> [<a href="/pubmed/12847533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12847533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.heil.2007.811">Heil SG, Hogeveen M, Kluijtmans LA, van Dijken PJ, van de Berg GB, Blom HJ, Morava E. Marfanoid features in a child with combined methylmalonic aciduria and homocystinuria (CblC type). <span><span class="ref-journal">J Inherit Metab Dis. </span>2007;<span class="ref-vol">30</span>:811.</span> [<a href="/pubmed/17768669" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17768669</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.higginbottom.1978.317">Higginbottom MC, Sweetman L, Nyhan WL. A syndrome of methylmalonic aciduria, homocystinuria, megaloblastic anemia and neurologic abnormalities in a vitamin B12-deficient breast-fed infant of a strict vegetarian. <span><span class="ref-journal">N Engl J Med. </span>1978;<span class="ref-vol">299</span>:317–23.</span> [<a href="/pubmed/683264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 683264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.hill.2004.116">Hill KP, Lukonis CJ, Korson MS, Weinstein C, Thall M, Schwartz JT. Neuropsychiatric illness in a patient with cobalamin G disease, an inherited disorder of vitamin B12 metabolism. <span><span class="ref-journal">Harv Rev Psychiatry. </span>2004;<span class="ref-vol">12</span>:116–22.</span> [<a href="/pubmed/15204806" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15204806</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.holzinger.1998.238">Holzinger A, Roscher AA, Landgraf P, Lichtner P, Kammerer S. Genomic organization and chromosomal localization of the human peroxisomal membrane protein-1-like protein (PXMP1-L) gene encoding a peroxisomal ABC transporter. <span><span class="ref-journal">FEBS Lett. </span>1998;<span class="ref-vol">426</span>:238–42.</span> [<a href="/pubmed/9599016" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9599016</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.homolova.2010.437">Homolova K, Zavad&#x000e1;kov&#x000e1; P, Doktor TK, Schroeder LD, Kozich V, Andresen BS. The deep intronic c.903+469T&#x0003e;C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria. <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:437–44.</span> [<a href="/pmc/articles/PMC3429857/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3429857</span></a>] [<a href="/pubmed/20120036" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20120036</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.huang.2012.694">Huang L, Jolly LA, Willis-Owen S, Gardner A, Kumar R, Douglas E, Shoubridge C, Wieczorek D, Tzschach A, Cohen M, Hackett A, Field M, Froyen G, Hu H, Haas SA, Ropers HH, Kalscheuer VM, Corbett MA, Gecz J. A noncoding, regulatory mutation implicates HCFC1 in nonsyndromic intellectual disability. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">91</span>:694–702.</span> [<a href="/pmc/articles/PMC3484651/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3484651</span></a>] [<a href="/pubmed/23000143" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23000143</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.huemer.2015a.957">Huemer M, Burer C, Jesina P, Kozich V, Landolt MA, Suormala T, Fowler B, Augoustides-Savvopoulou P, Blair E, Brennerova K, Broomfield A, De Meirleir L, Gokcay G, Hennermann J, Jardine P, Koch J, Lorenzl S, Lotz-Havla AS, Noss J, Parini R, Peters H, Plecko B, Ramos FJ, Schlune A, Tsiakas K, Zerjav Tansek M, Baumgartner MR. Clinical onset and course, response to treatment and outcome in 24 patients with the cblE or cblG remethylation defect complemented by genetic and in vitro enzyme study data. <span><span class="ref-journal">J Inherit Metab Dis. </span>2015a;<span class="ref-vol">38</span>:957–67.</span> [<a href="/pubmed/25526710" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25526710</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.huemer.2017.21">Huemer M, Diodato D, Schwahn B, Schiff M, Bandeira A, Benoist JF, Burlina A, Cerone R, Couce ML, Garcia-Cazorla A, la Marca G, Pasquini E, Vilarinho L, Weisfeld-Adams JD, Kozich V, Blom H, Baumgartner MR, Dionisi-Vici C. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. <span><span class="ref-journal">J Inherit Metab Dis. </span>2017;<span class="ref-vol">40</span>:21–48.</span> [<a href="/pmc/articles/PMC5203859/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5203859</span></a>] [<a href="/pubmed/27905001" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27905001</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.huemer.2015b.1007">Huemer M, Kozich V, Rinaldo P, Baumgartner MR, Merinero B, Pasquini E, Ribes A, Blom HJ. Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines. <span><span class="ref-journal">J Inherit Metab Dis. </span>2015b;<span class="ref-vol">38</span>:1007–19.</span> [<a href="/pmc/articles/PMC4626539/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4626539</span></a>] [<a href="/pubmed/25762406" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25762406</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.huemer.2014.161">Huemer M, Scholl-Burgi S, Hadaya K, Kern I, Beer R, Seppi K, Fowler B, Baumgartner MR, Karall D. Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2014;<span class="ref-vol">9</span>:161.</span> [<a href="/pmc/articles/PMC4255922/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4255922</span></a>] [<a href="/pubmed/25398587" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25398587</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.huemer.2005.469">Huemer M, Simma B, Fowler B, Suormala T, Bodamer OA, Sass JO. Prenatal and postnatal treatment in cobalamin C defect. <span><span class="ref-journal">J Pediatr. </span>2005;<span class="ref-vol">147</span>:469–72.</span> [<a href="/pubmed/16227032" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16227032</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.jolly.2015.3335">Jolly LA, Nguyen LS, Domingo D, Sun Y, Barry S, Hancarova M, Plevova P, Vlckova M, Havlovicova M, Kalscheuer VM, Graziano C, Pippucci T, Bonora E, Sedlacek Z, Gecz J. HCFC1 loss-of-function mutations disrupt neuronal and neural progenitor cells of the developing brain. <span><span class="ref-journal">Hum Mol Genet. </span>2015;<span class="ref-vol">24</span>:3335–47.</span> [<a href="/pubmed/25740848" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25740848</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.kaikov.1991.841">Kaikov Y, Wadsworth LD, Hall CA, Rogers PC. Transcobalamin II deficiency: case report and review of the literature. <span><span class="ref-journal">Eur J Pediatr. </span>1991;<span class="ref-vol">150</span>:841–3.</span> [<a href="/pubmed/1743216" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1743216</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.kim.2012.664">Kim JC, Lee NC, Wuh-Lian Hwu P, Chien YH, Fahiminiya S, Majewski J, Watkins D, Rosenblatt DS. Late onset of symptoms in an atypical patient with the cblJ inborn error of vitamin B(12) metabolism: diagnosis and novel mutation revealed by exome sequencing. <span><span class="ref-journal">Mol Genet Metab. </span>2012;<span class="ref-vol">107</span>:664–8.</span> [<a href="/pubmed/23141461" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23141461</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.kind.2002.327">Kind T, Levy J, Lee M, Kaicker S, Nicholson JF, Kane SA. Cobalamin C disease presenting as hemolytic-uremic syndrome in the neonatal period. <span><span class="ref-journal">J Pediatr Hematol Oncol. </span>2002;<span class="ref-vol">24</span>:327–9.</span> [<a href="/pubmed/11972107" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11972107</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.k_mhoff.2013.e540">K&#x000f6;mhoff M, Roofthooft MT, Westra D, Teertstra TK, Losito A, van de Kar NC, Berger RM. Combined pulmonary hypertension and renal thrombotic microangiopathy in cobalamin C deficiency. <span><span class="ref-journal">Pediatrics. </span>2013;<span class="ref-vol">132</span>:e540–4.</span> [<a href="/pubmed/23837176" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23837176</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.kondo.1981.1270">Kondo H, Osborne ML, Kolhouse JF, Binder MJ, Podell ER, Utley CS, Abrams RS, Allen RH. Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats. <span><span class="ref-journal">J Clin Invest. </span>1981;<span class="ref-vol">67</span>:1270–83.</span> [<a href="/pmc/articles/PMC370693/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC370693</span></a>] [<a href="/pubmed/6112240" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6112240</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.koufaris.2016.215">Koufaris C, Alexandrou A, Tanteles GA, Anastasiadou V, Sismani C. A novel HCFC1 variant in male siblings with intellectual disability and microcephaly in the absence of cobalamin disorder. <span><span class="ref-journal">Biomed Rep. </span>2016;<span class="ref-vol">4</span>:215–8.</span> [<a href="/pmc/articles/PMC4733959/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4733959</span></a>] [<a href="/pubmed/26893841" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26893841</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.koutmos.2011.29780">Koutmos M, Gherasim C, Smith JL, Banerjee R. Structural basis of multifunctionality in a vitamin B12-processing enzyme. <span><span class="ref-journal">J Biol Chem. </span>2011;<span class="ref-vol">286</span>:29780–7.</span> [<a href="/pmc/articles/PMC3191019/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3191019</span></a>] [<a href="/pubmed/21697092" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21697092</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.labrune.1999.734">Labrune P, Zittoun J, Duvaltier I, Trioche P, Marquet J, Niaudet P, Odievre M. Haemolytic uraemic syndrome and pulmonary hypertension in a patient with methionine synthase deficiency. <span><span class="ref-journal">Eur J Pediatr. </span>1999;<span class="ref-vol">158</span>:734–9.</span> [<a href="/pubmed/10485306" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10485306</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.leclerc.1996.1867">Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, Eydoux P, Rosenblatt DS, Rozen R, Gravel RA. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. <span><span class="ref-journal">Hum Mol Genet. </span>1996;<span class="ref-vol">5</span>:1867–74.</span> [<a href="/pubmed/8968737" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8968737</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.leclerc.1999.75">Leclerc D, Odievre M, Wu Q, Wilson A, Huizenga JJ, Rozen R, Scherer SW, Gravel RA. Molecular cloning, expression and physical mapping of the human methionine synthase reductase gene. <span><span class="ref-journal">Gene. </span>1999;<span class="ref-vol">240</span>:75–88.</span> [<a href="/pubmed/10564814" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10564814</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.lernerellis.2009.1072">Lerner-Ellis JP, Anastasio N, Liu J, Coelho D, Suormala T, Stucki M, Loewy AD, Gurd S, Grundberg E, Morel CF, Watkins D, Baumgartner MR, Pastinen T, Rosenblatt DS, Fowler B. Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations. <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:1072–81.</span> [<a href="/pubmed/19370762" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19370762</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.lernerellis.2006.93">Lerner-Ellis JP, Tirone JC, Pawelek PD, Dore C, Atkinson JL, Watkins D, Morel CF, Fujiwara TM, Moras E, Hosack AR, Dunbar GV, Antonicka H, Forgetta V, Dobson CM, Leclerc D, Gravel RA, Shoubridge EA, Coulton JW, Lepage P, Rommens JM, Morgan K, Rosenblatt DS. Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:93–100.</span> [<a href="/pubmed/16311595" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16311595</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.lin.2009.924">Lin HJ, Neidich JA, Salazar D, Thomas-Johnson E, Ferreira BF, Kwong AM, Lin AM, Jonas AJ, Levine S, Lorey F, Rosenblatt DS. Asymptomatic maternal combined homocystinuria and methylmalonic aciduria (cblC) detected through low carnitine levels on newborn screening. <span><span class="ref-journal">J Pediatr. </span>2009;<span class="ref-vol">155</span>:924–7.</span> [<a href="/pubmed/19914430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19914430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.liu.2017.58">Liu J, Peng Y, Zhou N, Liu X, Meng Q, Xu H, Zhao S. Combined methylmalonic acidemia and homocysteinemia presenting predominantly with late-onset diffuse lung disease: a case series of four patients. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2017;<span class="ref-vol">12</span>:58.</span> [<a href="/pmc/articles/PMC5360033/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5360033</span></a>] [<a href="/pubmed/28327205" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28327205</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.liu.2010.621">Liu MY, Yang YL, Chang YC, Chiang SH, Lin SP, Han LS, Qi Y, Hsiao KJ, Liu TT. Mutation spectrum of MMACHC in Chinese patients with combined methylmalonic aciduria and homocystinuria. <span><span class="ref-journal">J Hum Genet. </span>2010;<span class="ref-vol">55</span>:621–6.</span> [<a href="/pubmed/20631720" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20631720</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.liu.2015.286">Liu Y, Wang Q, Li X, Ding Y, Song J, Yang Y. First Chinese case of successful pregnancy with combined methylmalonic aciduria and homocystinuria, cblC type. <span><span class="ref-journal">Brain Dev. </span>2015;<span class="ref-vol">37</span>:286–91.</span> [<a href="/pubmed/24974159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24974159</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.longo.2005.366">Longo D, Fariello G, Dionisi-Vici C, Cannata V, Boenzi S, Genovese E, Deodato F. MRI and 1H-MRS findings in early-onset cobalamin C/D defect. <span><span class="ref-journal">Neuropediatrics. </span>2005;<span class="ref-vol">36</span>:366–72.</span> [<a href="/pubmed/16429376" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16429376</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.maines.2017.29">Maines E, Morandi G, Gugelmo G, Ion-Popa F, Campostrini N, Pasini A, Vincenzi M, Teofoli F, Camilot M, Bordugo A. Vitamin B12 administration by subcutaneous catheter device in a cobalamin A (cblA) patient. <span><span class="ref-journal">JIMD Rep. </span>2017;<span class="ref-vol">35</span>:29–31.</span> [<a href="/pmc/articles/PMC5585097/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5585097</span></a>] [<a href="/pubmed/27858373" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27858373</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.manoli.2016.396">Manoli I, Myles JG, Sloan JL, Carrillo-Carrasco N, Morava E, Strauss KA, Morton H, Venditti CP. A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 2: cobalamin C deficiency. <span><span class="ref-journal">Genet Med. </span>2016;<span class="ref-vol">18</span>:396–404.</span> [<a href="/pmc/articles/PMC4752912/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4752912</span></a>] [<a href="/pubmed/26270766" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26270766</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.martens.2002.219">Martens DH, Bakker JA, van der Meer SB, Spaapen LJ. Unexplained familial benign methylmalonic aciduria. <span><span class="ref-journal">Eur J Pediatr. </span>2002;<span class="ref-vol">161</span>:219–20.</span> [<a href="/pubmed/12014390" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12014390</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.matos.2013.360">Matos IV, Castejon E, Meavilla S, O'Callaghan M, Garcia-Villoria J, Lopez-Sala A, Ribes A, Artuch R, Garcia-Cazorla A. Clinical and biochemical outcome after hydroxocobalamin dose escalation in a series of patients with cobalamin C deficiency. <span><span class="ref-journal">Mol Genet Metab. </span>2013;<span class="ref-vol">109</span>:360–5.</span> [<a href="/pubmed/23746552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23746552</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.miousse.2009.551">Miousse IR, Watkins D, Coelho D, Rupar T, Crombez EA, Vilain E, Bernstein JA, Cowan T, Lee-Messer C, Enns GM, Fowler B, Rosenblatt DS. Clinical and molecular heterogeneity in patients with the cblD inborn error of cobalamin metabolism. <span><span class="ref-journal">J Pediatr. </span>2009;<span class="ref-vol">154</span>:551–6.</span> [<a href="/pubmed/19058814" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19058814</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.miousse.2011.505">Miousse IR, Watkins D, Rosenblatt DS. Novel splice site mutations and a large deletion in three patients with the cblF inborn error of vitamin B12 metabolism. <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">102</span>:505–7.</span> [<a href="/pubmed/21303734" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21303734</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.morel.2006.315">Morel CF, Lerner-Ellis JP, Rosenblatt DS. Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations. <span><span class="ref-journal">Mol Genet Metab. </span>2006;<span class="ref-vol">88</span>:315–21.</span> [<a href="/pubmed/16714133" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16714133</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.morel.2005.160">Morel CF, Watkins D, Scott P, Rinaldo P, Rosenblatt DS. Prenatal diagnosis for methylmalonic acidemia and inborn errors of vitamin B12 metabolism and transport. <span><span class="ref-journal">Mol Genet Metab. </span>2005;<span class="ref-vol">86</span>:160–71.</span> [<a href="/pubmed/16150626" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16150626</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.nogueira.2008.475">Nogueira C, Aiello C, Cerone R, Martins E, Caruso U, Moroni I, Rizzo C, Diogo L, Le&#x000e3;o E, Kok F, Deodato F, Schiaffino MC, Boenzi S, Danhaive O, Barbot C, Sequeira S, Locatelli M, Santorelli FM, Uziel G, Vilarinho L, Dionisi-Vici C. Spectrum of MMACHC mutations in Italian and Portuguese patients with combined methylmalonic aciduria and homocystinuria, cblC type. <span><span class="ref-journal">Mol Genet Metab. </span>2008;<span class="ref-vol">93</span>:475–80.</span> [<a href="/pubmed/18164228" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18164228</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.palanca.2013.57">Palanca D, Garcia-Cazorla A, Ortiz J, Jou C, Cusi V, Sunol M, Toll T, Perez B, Ormazabal A, Fowler B, Artuch R. cblE-type homocystinuria presenting with features of haemolytic-uremic syndrome in the newborn period. <span><span class="ref-journal">JIMD Rep. </span>2013;<span class="ref-vol">8</span>:57–62.</span> [<a href="/pmc/articles/PMC3565672/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3565672</span></a>] [<a href="/pubmed/23430521" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23430521</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.patton.2000.151">Patton N, Beatty S, Lloyd IC, Wraith JE. Optic atrophy in association with cobalamin C (cblC) disease. <span><span class="ref-journal">Ophthalmic Genet. </span>2000;<span class="ref-vol">21</span>:151–4.</span> [<a href="/pubmed/11035547" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11035547</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.paul.2013.1135">Paul EA, Guttenberg M, Kaplan P, Watkins D, Rosenblatt DS, Treat JR, Kaplan BS. Atypical glomerulopathy associated with the cblE inborn error of vitamin B(1)(2) metabolism. <span><span class="ref-journal">Pediatr Nephrol. </span>2013;<span class="ref-vol">28</span>:1135–9.</span> [<a href="/pubmed/23503767" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23503767</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.plesa.2011.139">Plesa M, Kim J, Paquette SG, Gagnon H, Ng-Thow-Hing C, Gibbs BF, Hancock MA, Rosenblatt DS, Coulton JW. Interaction between MMACHC and MMADHC, two human proteins participating in intracellular vitamin B metabolism. <span><span class="ref-journal">Mol Genet Metab. </span>2011;<span class="ref-vol">102</span>:139–48.</span> [<a href="/pubmed/21071249" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21071249</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.poloschek.2005.497">Poloschek CM, Fowler B, Unsold R, Lorenz B. Disturbed visual system function in methionine synthase deficiency. <span><span class="ref-journal">Graefes Arch Clin Exp Ophthalmol. </span>2005;<span class="ref-vol">243</span>:497–500.</span> [<a href="/pubmed/15931548" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15931548</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.powers.2001.396">Powers JM, Rosenblatt DS, Schmidt RE, Cross AH, Black JT, Moser AB, Moser HW, Morgan DJ. Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiency. <span><span class="ref-journal">Ann Neurol. </span>2001;<span class="ref-vol">49</span>:396–400.</span> [<a href="/pubmed/11261516" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11261516</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.profitlich.2009.344">Profitlich LE, Kirmse B, Wasserstein MP, Diaz GA, Srivastava S. High prevalence of structural heart disease in children with cblC-type methylmalonic aciduria and homocystinuria. <span><span class="ref-journal">Mol Genet Metab. </span>2009;<span class="ref-vol">98</span>:344–8.</span> [<a href="/pubmed/19767224" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19767224</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.pupavac.2016.976">Pupavac M, Watkins D, Petrella F, Fahiminiya S, Janer A, Cheung W, Gingras AC, Pastinen T, Muenzer J, Majewski J, Shoubridge EA, Rosenblatt DS. Inborn error of cobalamin metabolism associated with the intracellular accumulation of transcobalamin-bound cobalamin and mutations in ZNF143, which codes for a transcriptional activator. <span><span class="ref-journal">Hum Mutat. </span>2016;<span class="ref-vol">37</span>:976–82.</span> [<a href="/pubmed/27349184" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27349184</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.quadros.2010.924">Quadros EV, Lai SC, Nakayama Y, Sequeira JM, Hannibal L, Wang S, Jacobsen DW, Fedosov S, Wright E, Gallagher RC, Anastasio N, Watkins D, Rosenblatt DS. Positive newborn screen for methylmalonic aciduria identifies the first mutation in TCblR/CD320, the gene for cellular uptake of transcobalamin-bound vitamin B(12). <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:924–9.</span> [<a href="/pmc/articles/PMC2909035/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2909035</span></a>] [<a href="/pubmed/20524213" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20524213</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.quintana.2017.2838">Quintana AM, Yu HC, Brebner A, Pupavac M, Geiger EA, Watson A, Castro VL, Cheung W, Chen SH, Watkins D, Pastinen T, Skovby F, Appel B, Rosenblatt DS, Shaikh TH. Mutations in THAP11 cause an inborn error of cobalamin metabolism and developmental abnormalities. <span><span class="ref-journal">Hum Mol Genet. </span>2017;<span class="ref-vol">26</span>:2838–49.</span> [<a href="/pmc/articles/PMC5886234/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5886234</span></a>] [<a href="/pubmed/28449119" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28449119</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.refsum.2004.3">Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, Johnston C, Engbaek F, Schneede J, McPartlin C, Scott JM. Facts and recommendations about total homocysteine determinations: an expert opinion. <span><span class="ref-journal">Clin Chem. </span>2004;<span class="ref-vol">50</span>:3–32.</span> [<a href="/pubmed/14709635" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14709635</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.ribes.1990.412">Ribes A, Briones P, Vilaseca MA, Lluch M, Rodes M, Maya A, Campistol J, Pascual P, Suormala T, Baumgartner R. Methylmalonic aciduria with homocystinuria: biochemical studies, treatment, and clinical course of a Cbl-C patient. <span><span class="ref-journal">Eur J Pediatr. </span>1990;<span class="ref-vol">149</span>:412–5.</span> [<a href="/pubmed/2332011" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2332011</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.rosenblatt.1997.528">Rosenblatt DS, Aspler AL, Shevell MI, Pletcher BA, Fenton WA, Seashore MR. Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC). <span><span class="ref-journal">J Inherit Metab Dis. </span>1997;<span class="ref-vol">20</span>:528–38.</span> [<a href="/pubmed/9266389" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9266389</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.rossi.2001.554">Rossi A, Cerone R, Biancheri R, Gatti R, Schiaffino MC, Fonda C, Zammarchi E, Tortori-Donati P. Early-onset combined methylmalonic aciduria and homocystinuria: neuroradiologic findings. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2001;<span class="ref-vol">22</span>:554–63.</span> [<a href="/pubmed/11237984" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11237984</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.roze.2003.1457">Roze E, Gervais D, Demeret S, Ogier de Baulny H, Zittoun J, Benoist JF, Said G, Pierrot-Deseilligny C, Bolgert F. Neuropsychiatric disturbances in presumed late-onset cobalamin C disease. <span><span class="ref-journal">Arch Neurol. </span>2003;<span class="ref-vol">60</span>:1457–62.</span> [<a href="/pubmed/14568819" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14568819</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.rutsch.2009.234">Rutsch F, Gailus S, Miousse IR, Suormala T, Sagne C, Toliat MR, Nurnberg G, Wittkampf T, Buers I, Sharifi A, Stucki M, Becker C, Matthias B, Robenek H, Marquardt T, Hohne W, Gasnier B, Rosenblatt DS, Fowler B, Nurnberg P. Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B12 metabolism. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:234–9.</span> [<a href="/pubmed/19136951" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19136951</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.scalais.2017.65">Scalais E, Osterheld E, Weitzel C, De Meirleir L, Mataigne F, Martens G, Shaikh TH, Coughlin CR 2nd, Yu HC, Swanson M, Friederich MW, Scharer G, Helbling D, Wendt-Andrae J, Van Hove JLK. X-linked cobalamin disorder (HCFC1) mimicking nonketotic hyperglycinemia with increased both cerebrospinal fluid glycine and methylmalonic acid. <span><span class="ref-journal">Pediatr Neurol. </span>2017;<span class="ref-vol">71</span>:65–9.</span> [<a href="/pubmed/28363510" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28363510</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.shani.1997.1925">Shani N, Jimenez-Sanchez G, Steel G, Dean M, Valle D. Identification of a fourth half ABC transporter in the human peroxisomal membrane. <span><span class="ref-journal">Hum Mol Genet. </span>1997;<span class="ref-vol">6</span>:1925–31.</span> [<a href="/pubmed/9302272" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9302272</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.sharma.2007.2097">Sharma AP, Greenberg CR, Prasad AN, Prasad C. Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder. <span><span class="ref-journal">Pediatr Nephrol. </span>2007;<span class="ref-vol">22</span>:2097–103.</span> [<a href="/pubmed/17874135" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17874135</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.sloan.2011.883">Sloan JL, Johnston JJ, Manoli I, Chandler RJ, Krause C, Carrillo-Carrasco N, Chandrasekaran SD, Sysol JR, O'Brien K, Hauser NS, Sapp JC, Dorward HM, Huizing M., NIH Intramural Sequencing Center Group.  Barshop BA, Berry SA, James PM, Champaigne NL, de Lonlay P, Valayannopoulos V, Geschwind MD, Gavrilov DK, Nyhan WL, Biesecker LG, Venditti CP. Exome sequencing identifies ACSF3 as a cause of combined malonic and methylmalonic aciduria. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>:883–6.</span> [<a href="/pmc/articles/PMC3163731/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3163731</span></a>] [<a href="/pubmed/21841779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21841779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.smith.2006.138">Smith SE, Kinney HC, Swoboda KJ, Levy HL. Subacute combined degeneration of the spinal cord in cblC disorder despite treatment with B12. <span><span class="ref-journal">Mol Genet Metab. </span>2006;<span class="ref-vol">88</span>:138–45.</span> [<a href="/pubmed/16574454" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16574454</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.sniderman.1999.675">Sniderman LC, Lambert M, Giguere R, Auray-Blais C, Lemieux B, Laframboise R, Rosenblatt DS, Treacy EP. Outcome of individuals with low-moderate methylmalonic aciduria detected through a neonatal screening program. <span><span class="ref-journal">J Pediatr. </span>1999;<span class="ref-vol">134</span>:675–80.</span> [<a href="/pubmed/10356133" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10356133</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.stucki.2012.1410">Stucki M, Coelho D, Suormala T, Burda P, Fowler B, Baumgartner MR. Molecular mechanisms leading to three different phenotypes in the cblD defect of intracellular cobalamin metabolism. <span><span class="ref-journal">Human molecular genetics. </span>2012;<span class="ref-vol">21</span>:1410–8.</span> [<a href="/pubmed/22156578" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22156578</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.suormala.2004.42742">Suormala T, Baumgartner MR, Coelho D, Zavad&#x000e1;kov&#x000e1; P, Kozich V, Koch HG, Berghauser M, Wraith JE, Burlina A, Sewell A, Herwig J, Fowler B. The cblD defect causes either isolated or combined deficiency of methylcobalamin and adenosylcobalamin synthesis. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:42742–9.</span> [<a href="/pubmed/15292234" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15292234</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.takeichi.2015.1111">Takeichi T, Hsu CK, Yang HS, Chen HY, Wong TW, Tsai WL, Chao SC, Lee JY, Akiyama M, Simpson MA, McGrath JA. Progressive hyperpigmentation in a Taiwanese child due to an inborn error of vitamin B12 metabolism (cblJ). <span><span class="ref-journal">Br J Dermatol. </span>2015;<span class="ref-vol">172</span>:1111–5.</span> [<a href="/pubmed/25234635" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25234635</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.tanpaiboon.2013.33">Tanpaiboon P, Sloan JL, Callahan PF, McAreavey D, Hart PS, Lichter-Konecki U, Zand D, Venditti CP. Noncompaction of the ventricular myocardium and hydrops fetalis in cobalamin C disease. <span><span class="ref-journal">JIMD Rep. </span>2013;<span class="ref-vol">10</span>:33–8.</span> [<a href="/pmc/articles/PMC3755569/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3755569</span></a>] [<a href="/pubmed/23430797" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23430797</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.thauvinrobinet.2008.725">Thauvin-Robinet C, Roze E, Couvreur G, Horellou MH, Sedel F, Grabli D, Bruneteau G, Tonneti C, Masurel-Paulet A, Perennou D, Moreau T, Giroud M, de Baulny HO, Giraudier S, Faivre L. The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2008;<span class="ref-vol">79</span>:725–8.</span> [<a href="/pubmed/18245139" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18245139</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.tomaske.2001.511">Tomaske M, Bosk A, Heinemann MK, Sieverding L, Baumgartner ER, Folwer B, Trefz FK. CblC/D defect combined with haemodynamically highly relevant VSD. <span><span class="ref-journal">J Inherit Metab Dis. </span>2001;<span class="ref-vol">24</span>:511–2.</span> [<a href="/pubmed/11596656" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11596656</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.trefz.2016.55">Trefz FK, Scheible D, Frauendienst-Egger G, Huemer M, Suomala T, Fowler B, Haas D, Baumgartner MR. Successful intrauterine treatment of a patient with cobalamin C defect. <span><span class="ref-journal">Mol Genet Metab Rep. </span>2016;<span class="ref-vol">6</span>:55–59.</span> [<a href="/pmc/articles/PMC4789385/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4789385</span></a>] [<a href="/pubmed/27014578" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27014578</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.tsai.2007.2430">Tsai AC, Morel CF, Scharer G, Yang M, Lerner-Ellis JP, Rosenblatt DS, Thomas JA. Late-onset combined homocystinuria and methylmalonic aciduria (cblC) and neuropsychiatric disturbance. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:2430–4.</span> [<a href="/pubmed/17853453" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17853453</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.tschudy.2012">Tschudy MM, Arcara KM. <em>The Harriet Lane Handbook.</em> Johns Hopkins Hospital. Philadelphia, PA: Mosby Elsevier; 2012.</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.tuchman.1988.1052">Tuchman M, Kelly P, Watkins D, Rosenblatt DS. Vitamin B12-responsive megaloblastic anemia, homocystinuria, and transient methylmalonic aciduria in cblE disease. <span><span class="ref-journal">J Pediatr. </span>1988;<span class="ref-vol">113</span>:1052–6.</span> [<a href="/pubmed/3193313" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3193313</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.ubbink.2000.233">Ubbink JB. Assay methods for the measurement of total homocyst(e)ine in plasma. <span><span class="ref-journal">Semin Thromb Hemost. </span>2000;<span class="ref-vol">26</span>:233–41.</span> [<a href="/pubmed/11011841" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11011841</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.vaisbich.2017.1089">Vaisbich MH, Braga A, Gabrielle M, Bueno C, Piazzon F, Kok F. Thrombotic microangiopathy caused by methionine synthase deficiency: diagnosis and treatment pitfalls. <span><span class="ref-journal">Pediatr Nephrol. </span>2017;<span class="ref-vol">32</span>:1089–92.</span> [<a href="/pubmed/28210839" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28210839</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.van_hove.2002.195">Van Hove JL, Van Damme-Lombaerts R, Grunewald S, Peters H, Van Damme B, Fryns JP, Fowler B. Cobalamin disorder Cbl-C presenting with late-onset thrombotic microangiopathy. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">111</span>:195–201.</span> [<a href="/pubmed/12210350" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12210350</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.wang.2009.189">Wang F, Han LS, Hu YH, Yang YL, Ye J, Qiu WJ, Zhang YF, Gao XL, Wang Y, Gu XF. Analysis of gene mutations in Chinese patients with methylmalonic acidemia and homocysteinemia. <span><span class="ref-journal">Zhonghua Er Ke Za Zhi. </span>2009;<span class="ref-vol">47</span>:189–93.</span> [<a href="/pubmed/19573432" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19573432</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.watkins.1986.404">Watkins D, Rosenblatt DS. Failure of lysosomal release of vitamin B12: a new complementation group causing methylmalonic aciduria (cblF). <span><span class="ref-journal">Am J Hum Genet. </span>1986;<span class="ref-vol">39</span>:404–8.</span> [<a href="/pmc/articles/PMC1683971/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1683971</span></a>] [<a href="/pubmed/3766542" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3766542</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.watkins.1989.427">Watkins D, Rosenblatt DS. Functional methionine synthase deficiency (cblE and cblG): clinical and biochemical heterogeneity. <span><span class="ref-journal">Am J Med Genet. </span>1989;<span class="ref-vol">34</span>:427–34.</span> [<a href="/pubmed/2688421" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2688421</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.watkins.2014">Watkins D, Rosenblatt DS. Inherited disorders of folate and cobalamin transport and metabolism. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <em>The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID).</em> Chap 155. New York, NY: McGraw-Hill; 2014.</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.watkins.2002.143">Watkins D, Ru M, Hwang HY, Kim CD, Murray A, Philip NS, Kim W, Legakis H, Wai T, Hilton JF, Ge B, Dore C, Hosack A, Wilson A, Gravel RA, Shane B, Hudson TJ, Rosenblatt DS. Hyperhomocysteinemia due to methionine synthase deficiency, cblG: structure of the MTR gene, genotype diversity, and recognition of a common mutation, P1173L. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">71</span>:143–53.</span> [<a href="/pmc/articles/PMC384971/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC384971</span></a>] [<a href="/pubmed/12068375" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12068375</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.weisfeldadams.2015.537">Weisfeld-Adams JD, McCourt EA, Diaz GA, Oliver SC. Ocular disease in the cobalamin C defect: a review of the literature and a suggested framework for clinical surveillance. <span><span class="ref-journal">Mol Genet Metab. </span>2015;<span class="ref-vol">114</span>:537–46.</span> [<a href="/pubmed/25742969" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25742969</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.weisfeldadams.2010.116">Weisfeld-Adams JD, Morrissey MA, Kirmse BM, Salveson BR, Wasserstein MP, McGuire PJ, Sunny S, Cohen-Pfeffer JL, Yu C, Caggana M, Diaz GA. Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte. <span><span class="ref-journal">Mol Genet Metab. </span>2010;<span class="ref-vol">99</span>:116–23.</span> [<a href="/pmc/articles/PMC2914534/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2914534</span></a>] [<a href="/pubmed/19836982" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19836982</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.wilson.1998.409">Wilson A, Leclerc D, Saberi F, Campeau E, Hwang HY, Shane B, Phillips JA 3rd, Rosenblatt DS, Gravel RA. Functionally null mutations in patients with the cblG-variant form of methionine synthase deficiency. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">63</span>:409–14.</span> [<a href="/pmc/articles/PMC1377317/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377317</span></a>] [<a href="/pubmed/9683607" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9683607</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.wong.2016.162">Wong D, Tortorelli S, Bishop L, Sellars EA, Schimmenti LA, Gallant N, Prada CE, Hopkin RJ, Leslie ND, Berry SA, Rosenblatt DS, Fair AL, Matern D, Raymond K, Oglesbee D, Rinaldo P, Gavrilov D. Outcomes of four patients with homocysteine remethylation disorders detected by newborn screening. <span><span class="ref-journal">Genet Med. </span>2016;<span class="ref-vol">18</span>:162–7.</span> [<a href="/pubmed/25856670" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25856670</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.yamada.2015.29155">Yamada K, Gherasim C, Banerjee R, Koutmos M. Structure of human B12 trafficking protein CblD reveals molecular mimicry and identifies a new subfamily of nitro-FMN reductases. <span><span class="ref-journal">J Biol Chem. </span>2015;<span class="ref-vol">290</span>:29155–66.</span> [<a href="/pmc/articles/PMC4705922/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4705922</span></a>] [<a href="/pubmed/26364851" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26364851</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.yamada.2006.9476">Yamada K, Gravel RA, Toraya T, Matthews RG. Human methionine synthase reductase is a molecular chaperone for human methionine synthase. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2006;<span class="ref-vol">103</span>:9476–81.</span> [<a href="/pmc/articles/PMC1480432/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1480432</span></a>] [<a href="/pubmed/16769880" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16769880</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.yu.2013.506">Yu HC, Sloan JL, Scharer G, Brebner A, Quintana AM, Achilly NP, Manoli I, Coughlin CR 2nd, Geiger EA, Schneck U, Watkins D, Suormala T, Van Hove JL, Fowler B, Baumgartner MR, Rosenblatt DS, Venditti CP, Shaikh TH. An X-linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1. <span><span class="ref-journal">Am J Hum Genet. </span>2013;<span class="ref-vol">93</span>:506–14.</span> [<a href="/pmc/articles/PMC3769968/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3769968</span></a>] [<a href="/pubmed/24011988" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24011988</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.zavad_kov_.2005.239">Zavad&#x000e1;kov&#x000e1; P, Fowler B, Suormala T, Novotna Z, Mueller P, Hennermann JB, Zeman J, Vilaseca MA, Vilarinho L, Gutsche S, Wilichowski E, Horneff G, Kozich V. cblE Type of homocystinuria due to methionine synthase reductase deficiency: functional correction by minigene expression. <span><span class="ref-journal">Hum Mutat. </span>2005;<span class="ref-vol">25</span>:239–47.</span> [<a href="/pubmed/15714522" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15714522</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cbl.REF.zavad_kov_.2002.461">Zavad&#x000e1;kov&#x000e1; P, Fowler B, Zeman J, Suormala T, Pristoupilova K, Kozich V, Zavad'akova P. CblE type of homocystinuria due to methionine synthase reductase deficiency: clinical and molecular studies and prenatal diagnosis in two families. <span><span class="ref-journal">J Inherit Metab Dis. </span>2002;<span class="ref-vol">25</span>:461–76.</span> [<a href="/pubmed/12555939" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12555939</span></a>]</div></li></ul></div></div><div id="cbl.Chapter_Notes"><h2 id="_cbl_Chapter_Notes_">Chapter Notes</h2><div id="cbl.Author_Notes"><h3>Author Notes</h3><p>Dr Sloan is a genetic counselor and researcher at the National Human Genome Research Institute at the National Institutes of Health.</p><p>Dr Carrillo is a pediatrician and biochemical geneticist. She is an attending physician at the National Human Genome Research Institute at the National Institutes of Health.</p><p>Dr Adams is a pediatrician and biochemical geneticist. He is an attending physician at the National Human Genome Research Institute at the National Institutes of Health.</p><p>Dr Venditti is a pediatrician and biochemical geneticist. He is the director of the Organic Acid Disorder Research Unit, a Senior Investigator in the National Human Genome Research Institute, and an attending physician at the National Institutes of Health Clinical Center.</p></div><div id="cbl.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>6 September 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>21 November 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 August 2009 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/targeted-mutation-analysis/">targeted mutation analysis</a> for c.271dupA mutation in cblC and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for cblD and variants available clinically.</div></li><li class="half_rhythm"><div>2 June 2009 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> available clinically for <i>MMADHC</i> mutations causing cblD, cblD variant 1, and cblD variant 2</div></li><li class="half_rhythm"><div>25 February 2008 (me) Review posted live</div></li><li class="half_rhythm"><div>22 December 2006 (cpv) Original submission</div></li></ul><p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <i>GeneReview</i> "Disorders of Intracellular Cobalamin Metabolism" is in the public <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> in the United States of America.</p></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1328</span><span class="label">PMID: <a href="/pubmed/20301503" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301503</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/gnas-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/donnai/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1328&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1328/?report=reader">PubReader</a></li><li><a href="/books/NBK1328/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1328" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1328" style="display:none" title="Cite this Page"><div class="bk_tt">Sloan JL, Carrillo N, Adams D, et al. Disorders of Intracellular Cobalamin Metabolism. 2008 Feb 25 [Updated 2018 Sep 6]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1328/pdf/Bookshelf_NBK1328.pdf">PDF version of this page</a> (1.1M)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cbl.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cbl.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#cbl.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cbl.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cbl.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#cbl.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cbl.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cbl.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cbl.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cbl.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cbl.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cbl.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3054[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HCFC1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=25974[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MMACHC</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=57215[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">THAP11</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=27249[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MMADHC</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55788[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">LMBRD1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7702[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ZNF143</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4548[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MTR</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5052[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PRDX1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4552[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MTRR</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5826[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ABCD4</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1463434" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1463434" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1463434" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1463434" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301409" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Isolated Methylmalonic Acidemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Isolated Methylmalonic Acidemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Manoli I, Sloan JL, Venditti CP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24006547" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lichter-Konecki U, Caldovic L, Morizono H, Simpson K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22593918" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shchelochkov OA, Carrillo N, Venditti C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301697" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sacharow SJ, Picker JD, Levy HL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31536184" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glutaric Acidemia Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glutaric Acidemia Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Larson A, Goodman S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301503" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301503" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042ace39a66ee2babba183">Disorders of Intracellular Cobalamin Metabolism - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Disorders of Intracellular Cobalamin Metabolism - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:36:46-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CC8CFE0427811000000000166008D&amp;ncbi_session=CE8CC8CFE042ACD1_0358SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1328%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1328&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1328/&amp;ncbi_pagename=Disorders of Intracellular Cobalamin Metabolism - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CC8CFE042ACD1_0358SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>